Target (101)
Compound (387)
Article Title (73)
Article Author (2)
Assay (407)
delta-aminolevulinic acid dehydratase 5-aminolevulinic acid synthase 2 d-ala-d-ala dipeptidase d-ala-d-ala ligase gamma-aminobutyric acid receptor subunit alpha-2/delta delta-type opioid receptor (delta) delta-8--delta-7 sterol isomerase gamma-aminobutyric acid receptor subunit alpha-4/beta3/delta 3-beta-hydroxysteroid-delta(8),delta(7)-isomerase/delta(24)-sterol reductase gamma-aminobutyric acid receptor subunit alpha-1/beta-2/delta gamma-aminobutyric acid receptor subunit alpha-1/beta-3/delta gamma-aminobutyric acid receptor subunit alpha-4/beta-1/delta gamma-aminobutyric acid receptor subunit alpha-4/beta-2/delta gamma-aminobutyric acid receptor subunit alpha-4/beta-3/delta gamma-aminobutyric acid receptor subunit alpha-6/beta-2/delta gamma-aminobutyric acid receptor subunit alpha-6/beta-3/delta delta-adaptin opiate delta pkc delta ppar delta ppar-delta tryptase delta cholestenol delta-isomerase delta carbonic anhydrase delta opioid receptor delta-coat protein diacylglycerol kinase delta mtor/ p110-delta p110-delta/ egfr p110-delta/ src p38 delta/gamma ppar delta protein phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform (pi3k-delta) acetylcholine receptor subunit delta casein kinase 1, delta delta(14)-sterol reductase delta-type opioid receptor map kinase p38 delta opioid receptor delta 1 opioid receptor, delta 1b p110-delta/ p110-alpha phospholipase c-delta-1 protein kinase c delta acetylcholine receptor protein delta chain cam kinase ii delta/gamma casein kinase 1 delta (ck1) casein kinase 1, delta tv1 casein kinase i delta/epsilon casein kinase i isoform delta delta sleep-inducing peptide immunoreactor dna polymerase (alpha/delta/epsilon) dna polymerase delta catalytic subunit dna polymerase delta subunit 1 dna polymerase delta subunit 2 dna polymerase delta subunit 3 dna polymerase subunit delta p125 gaba(a) receptor subunit delta glutamate receptor delta-2 subunit isopentenyl-diphosphate delta-isomerase 1 opioid receptors; mu and delta opioid receptors; mu/kappa/delta p110-delta/ src mutant (t338i) phosphoinositide 3-kinase (pi3k), delta phosphoinositide phospholipase c-delta-1 ptdins-3-kinase subunit delta sphingolipid delta(4)-desaturase des1 3-beta-hydroxysterol delta-24-reductase acetylcholine receptor; alpha1/beta1/delta/gamma casein kinase i isoform alpha/delta egfr delta 19/746/750 t790m pi3-kinase p110-delta/p85-alpha pp2a b subunit isoform b''-delta t-complex protein 1 subunit delta 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase delta-1 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase delta-4 acetylcholine receptor subunit alpha/beta/delta/epsilon acetylcholine receptor subunit alpha/beta/delta/gamma delta(4)-3-ketosteroid 5-beta-reductase eif2b gdp-gtp exchange factor subunit delta nicotinic acetylcholine receptor alpha1/beta1/epsilon/delta nicotinic acetylcholine receptor alpha1/beta1/gamma/delta peroxisome proliferator-activated receptor alpha/delta/gamma peroxisome proliferator-activated receptor delta [128-441] acetylcholine receptor protein alpha/beta/delta/gamma chain atp synthase f(1) complex subunit delta, mitochondrial delta-type/kappa-type/mu-type opioid receptor delta and notch-like epidermal growth factor-related receptor isoform 1 of misshapen-like kinase 1 (mink-delta) nicotinic acetylcholine receptor alpha-1/beta-1/delta/epsilon phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform voltage-dependent calcium channel subunit alpha-2/delta-1 voltage-gated calcium channel subunit alpha-2/delta-1 phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kda catalytic subunit delta rna-directed rna polymerase, c-terminally truncated form delta c21 phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform [14-604] phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform/gamma isoform calcium/calmodulin-dependent protein kinase type ii subunit alpha/beta/delta/gamma phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha/beta/delta/gamma isoform protein kinase c alpha/beta/delta/epsilon/eta/gamma/theta/zeta type voltage-dependent calcium channel subunit alpha-2/delta-1 (aa 25-1103)
Lentz, CS; Stumpfe, D; Bajorath, J; Famulok, M; Hoerauf, A; Pfarr, KM New chemotypes for wALADin1-like inhibitors of delta-aminolevulinic acid dehydratase from Wolbachia endobacteria. Bioorg Med Chem Lett 23: 5558 -62 (2013) Suzuki, C; Kato, K; Tsuji, AB; Kikuchi, T; Zhang, MR; Arano, Y; Saga, T Synthesis and in vitro cellular uptake of 11C-labeled 5-aminolevulinic acid derivative to estimate the induced cellular accumulation of protoporphyrin IX. Bioorg Med Chem Lett 23: 4567 -70 (2013) Kasuga, J; Ishida, S; Yamasaki, D; Makishima, M; Doi, T; Hashimoto, Y; Miyachi, H Novel biphenylcarboxylic acid peroxisome proliferator-activated receptor (PPAR) delta selective antagonists. Bioorg Med Chem Lett 19: 6595 -9 (2009) Sasaki, Y; Chiba, T Novel deltorphin heptapeptide analogs with potent delta agonist, delta antagonist, or mixed mu antagonist/delta agonist properties. J Med Chem 38: 3995 -9 (1995) Compton, DR; Prescott, WR; Martin, BR; Siegel, C; Gordon, PM; Razdan, RK Synthesis and pharmacological evaluation of ether and related analogues of delta 8-, delta 9-, and delta 9,11-tetrahydrocannabinol. J Med Chem 34: 3310 -6 (1991) Cantin, LD; Liang, S; Ogutu, H; Iwuagwu, CI; Boakye, K; Bullock, WH; Burns, M; Clark, R; Claus, T; delaCruz, FE; Daly, M; Ehrgott, FJ; Johnson, JS; Keiper, C; Livingston, JN; Schoenleber, RW; Shapiro, J; Town, C; Yang, L; Tsutsumi, M; Ma, X Indanylacetic acid derivatives carrying aryl-pyridyl and aryl-pyrimidinyl tail groups--new classes of PPAR gamma/delta and PPAR alpha/gamma/delta agonists. Bioorg Med Chem Lett 17: 1056 -61 (2007) Vakkalanka, SK; Muthuppalaniappan, M; Nagarathnam, D Selective PI3K delta inhibitors US Patent US9150579 (2015) Lebold, TP; McCarver, S; McClure, KJ; Preville, C; Seierstad, M; Shireman, BT; Wang, J; Wu, D; Zhang, W; Ziff, JM CASEIN KINASE 1 DELTA MODULATORS US Patent US20230339900 (2023) Loriga, G; Lazzari, P; Manca, I; Ruiu, S; Falzoi, M; Murineddu, G; Bottazzi, ME; Pinna, G; Pinna, GA Novel diazabicycloalkane delta opioid agonists. Bioorg Med Chem 23: 5527 -38 (2015) Portoghese, PS; Sultana, M; Moe, ST; Takemori, AE Synthesis of naltrexone-derived delta-opioid antagonists. Role of conformation of the delta address moiety. J Med Chem 37: 579 -85 (1994) Schiller, PW; Weltrowska, G; Nguyen, TM; Wilkes, BC; Chung, NN; Lemieux, C TIPP[psi]: a highly potent and stable pseudopeptide delta opioid receptor antagonist with extraordinary delta selectivity. J Med Chem 36: 3182 -7 (1993) Portoghese, PS; Sultana, M; Nelson, WL; Klein, P; Takemori, AE Delta opioid antagonist activity and binding studies of regioisomeric isothiocyanate derivatives of naltrindole: evidence for delta receptor subtypes. J Med Chem 35: 4086 -91 (1992) Fujita, Y; Tsuda, Y; Li, T; Motoyama, T; Takahashi, M; Shimizu, Y; Yokoi, T; Sasaki, Y; Ambo, A; Kita, A; Jinsmaa, Y; Bryant, SD; Lazarus, LH; Okada, Y Development of potent bifunctional endomorphin-2 analogues with mixed mu-/delta-opioid agonist and delta-opioid antagonist properties. J Med Chem 47: 3591 -9 (2004) Qian, X; Kövér, KE; Shenderovich, MD; Lou, BS; Misicka, A; Zalewska, T; Horváth, R; Davis, P; Bilsky, EJ; Porreca, F Newly discovered stereochemical requirements in the side-chain conformation of delta opioid agonists for recognizing opioid delta receptors. J Med Chem 37: 1746 -57 (1994) Kasuga, J; Makishima, M; Hashimoto, Y; Miyachi, H Design and synthesis of substituted phenylpropanoic acid derivatives as human peroxisome proliferator-activated receptor alpha/delta dual agonists. Bioorg Med Chem Lett 16: 554 -8 (2005) Chen, SH; Lamar, J; Guo, D; Kohn, T; Yang, HC; McGee, J; Timm, D; Erickson, J; Yip, Y; May, P; McCarthy, J P3 cap modified Phe*-Ala series BACE inhibitors. Bioorg Med Chem Lett 14: 245 -50 (2003) Wickens, P; Zhang, C; Ma, X; Zhao, Q; Amatruda, J; Bullock, W; Burns, M; Cantin, LD; Chuang, CY; Claus, T; Dai, M; Dela Cruz, F; Dickson, D; Ehrgott, FJ; Fan, D; Heald, S; Hentemann, M; Iwuagwu, CI; Johnson, JS; Kumarasinghe, E; Ladner, D; Lavoie, R; Liang, S; Livingston, JN; Lowe, D; Magnuson, S; Mannelly, G; Mugge, I; Ogutu, H; Pleasic-Williams, S; Schoenleber, RW; Shapiro, J; Shelekhin, T; Sweet, L; Town, C; Tsutsumi, M Indanylacetic acids as PPAR-delta activator insulin sensitizers. Bioorg Med Chem Lett 17: 4369 -73 (2007) Papahatjis, DP; Nikas, SP; Andreou, T; Makriyannis, A Novel 1',1'-chain substituted Delta(8)-tetrahydrocannabinols. Bioorg Med Chem Lett 12: 3583 -6 (2002) Fujii, H; Hayashida, K; Saitoh, A; Yokoyama, A; Hirayama, S; Iwai, T; Nakata, E; Nemoto, T; Sudo, Y; Uezono, Y; Yamada, M; Nagase, H Novel delta opioid receptor agonists with oxazatricyclodecane structure. ACS Med Chem Lett 5: 368 -72 (2014) McGowan, MA; Katz, JD; Zhou, H; Witter, DJ; Li, C; Lipford, KA; Methot, JL; Achab, AA; Fradera, X; Xu, S; Fu, J Purine inhibitors of human phosphatidylinositol 3-kinase delta US Patent US11179389 (2021) Bhushan, RG; Sharma, SK; Xie, Z; Daniels, DJ; Portoghese, PS A bivalent ligand (KDN-21) reveals spinal delta and kappa opioid receptors are organized as heterodimers that give rise to delta(1) and kappa(2) phenotypes. Selective targeting of delta-kappa heterodimers. J Med Chem 47: 2969 -72 (2004) Henry, JA; Horwell, DC; Meecham, KG; Rees, DC A structure-affinity study of the amino acid side-chains in neurotensin : N and C terminal deletions and Ala-scan Bioorg Med Chem Lett 3: 949 -952 (1993) Smith, TA; Thatcher, LN; Coop, A 3-Hydroxy-4-methoxyindolomorphinans as delta opioid selective ligands. Bioorg Med Chem Lett 17: 5175 -6 (2007) Korlipara, VL; Takemori, AE; Portoghese, PS Electrophilic N-benzylnaltrindoles as delta opioid receptor-selective antagonists. J Med Chem 38: 1337 -43 (1995) Fowler, KW; Huang, D; Kesicki, EA; Ooi, HC; Oliver, A; Ruan, F; Treiberg, J; Puri, KD Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta US Patent USRE44599 (2013) Portoghese, PS; Moe, ST; Takemori, AE A selective delta 1 opioid receptor agonist derived from oxymorphone. Evidence for separate recognition sites for delta 1 opioid receptor agonists and antagonists. J Med Chem 36: 2572 -4 (1993) Breveglieri, A; Guerrini, R; Salvadori, S; Bianchi, C; Bryant, SD; Attila, M; Lazarus, LH Design and synthesis of 1-aminocycloalkane-1-carboxylic acid-substituted deltorphin analogues: unique delta and mu opioid activity in modified peptides. J Med Chem 39: 773 -80 (1996) Liras, S; McHardy, SF; Allen, MP; Segelstein, BE; Heck, SD; Bryce, DK; Schmidt, AW; Vanase-Frawley, M; Callegari, E; McLean, S Biaryl piperidines as potent and selective delta opioid receptor ligands. Bioorg Med Chem Lett 20: 503 -7 (2010) Coop, A; Pinto, J; Wang, L; McCullough, K; Rothman, RB; Dersch, C; Jacobson, AE; Rice, KC Delta opioid binding selectivity of 3-ether analogs of naltrindole. Bioorg Med Chem Lett 9: 3435 -8 (2000) Nortey, SO; Baxter, EW; Codd, EE; Zhang, SP; Reitz, AB Piperazinyl benzamidines: synthesis and affinity for the delta opioid receptor. Bioorg Med Chem Lett 11: 1741 -3 (2001) Li, T; Fujita, Y; Shiotani, K; Miyazaki, A; Tsuda, Y; Ambo, A; Sasaki, Y; Jinsmaa, Y; Marczak, E; Bryant, SD; Salvadori, S; Lazarus, LH; Okada, Y Potent Dmt-Tic pharmacophoric delta- and mu-opioid receptor antagonists. J Med Chem 48: 8035 -44 (2005) Murray, JM; Sweeney, ZK; Chan, BK; Balazs, M; Bradley, E; Castanedo, G; Chabot, C; Chantry, D; Flagella, M; Goldstein, DM; Kondru, R; Lesnick, J; Li, J; Lucas, MC; Nonomiya, J; Pang, J; Price, S; Salphati, L; Safina, B; Savy, PP; Seward, EM; Ultsch, M; Sutherlin, DP Potent and highly selective benzimidazole inhibitors of PI3-kinase delta. J Med Chem 55: 7686 -95 (2012) Balboni, G; Salvadori, S; Guerrini, R; Negri, L; Giannini, E; Jinsmaa, Y; Bryant, SD; Lazarus, LH Potent delta-opioid receptor agonists containing the Dmt-Tic pharmacophore. J Med Chem 45: 5556 -63 (2002) Basséne, CE; Suzenet, F; Hennuyer, N; Staels, B; Caignard, DH; Dacquet, C; Renard, P; Guillaumet, G Studies towards the conception of new selective PPARbeta/delta ligands. Bioorg Med Chem Lett 16: 4528 -32 (2006) Seibel, J; Brown, D; Amour, A; Macdonald, SJ; Oldham, NJ; Schofield, CJ Synthesis and evaluation of delta-lactams (piperazones) as elastase inhibitors. Bioorg Med Chem Lett 13: 387 -9 (2003) Balboni, G; Guerrini, R; Salvadori, S; Negri, L; Giannini, E; Bryant, SD; Jinsmaa, Y; Lazarus, LH Conversion of the potent delta-opioid agonist H-Dmt-Tic-NH-CH(2)-bid into delta-opioid antagonists by N(1)-benzimidazole alkylation(1). J Med Chem 48: 8112 -4 (2005) Ullrich, T; Dersch, CM; Rothman, RB; Jacobson, AE; Rice, KC Derivatives of 17-(2-methylallyl)-substituted noroxymorphone: variation of the delta address and its effects on affinity and selectivity for the delta opioid receptor. Bioorg Med Chem Lett 11: 2883 -5 (2001) Balboni, G; Guerrini, R; Salvadori, S; Bianchi, C; Rizzi, D; Bryant, SD; Lazarus, LH Evaluation of the Dmt-Tic pharmacophore: conversion of a potent delta-opioid receptor antagonist into a potent delta agonist and ligands with mixed properties. J Med Chem 45: 713 -20 (2002) Taton, M; Benveniste, P; Rahier, A Microsomal delta 8,14-sterol delta 14-reductase in higher plants. Characterization and inhibition by analogues of a presumptive carbocationic intermediate of the reduction reaction. Eur J Biochem 185: 605 -14 (1989) Berardi, F; Abate, C; Ferorelli, S; de Robertis, AF; Leopoldo, M; Colabufo, NA; Niso, M; Perrone, R Novel 4-(4-aryl)cyclohexyl-1-(2-pyridyl)piperazines as Delta(8)-Delta(7) sterol isomerase (emopamil binding protein) selective ligands with antiproliferative activity. J Med Chem 51: 7523 -31 (2009) Mosberg, HI; Kroona, HB Incorporation of a novel conformationally restricted tyrosine analog into a cyclic, delta opioid receptor selective tetrapeptide (JOM-13) enhances delta receptor binding affinity and selectivity. J Med Chem 35: 4498 -500 (1992) Owen, DR; Rodriguez-Lens, M; Corless, MD; Gaulier, SM; Horne, VA; Kinloch, RA; Maw, GN; Pearce, DW; Rees, H; Ringer, TJ; Ryckmans, T; Stammen, BL 2,4-Diaminopyridine delta-opioid receptor agonists and their associated hERG pharmacology. Bioorg Med Chem Lett 19: 1702 -6 (2009) Hartung, AM; Navarro, HA; Wiemer, DF; Neighbors, JD A selective delta opioid receptor antagonist based on a stilbene core. Bioorg Med Chem Lett 25: 5532 -5 (2015) Minami, NK; Reiner, JE; Semple, JE Asymmetric synthesis of novel quaternary alpha-hydroxy-delta-lactam dipeptide surrogates. Bioorg Med Chem Lett 9: 2625 -8 (1999) Heffron, T; Safina, B; Staben, S; Sutherlin, DP; Wei, B; Elliott, R; Heald, R; Seward, EM; Gancia, E; Waszkowycz, B Benzoxazepin compounds selective for PI3K P110 delta and methods of use US Patent US9090628 (2015) Bartosz-Bechowski, H; Davis, P; Zalewska, T; Slaninova, J; Porreca, F; Yamamura, HI; Hruby, VJ Cyclic enkephalin analogs with exceptional potency at peripheral delta opioid receptors. J Med Chem 37: 146 -50 (1994) Leahy, JW Inhibitors of PI3K-delta and methods of their use and manufacture US Patent US9670212 (2017) Pagé, D; McClory, A; Mischki, T; Schmidt, R; Butterworth, J; St-Onge, S; Labarre, M; Payza, K; Brown, W Novel Dmt-Tic dipeptide analogues as selective delta-opioid receptor antagonists. Bioorg Med Chem Lett 10: 167 -70 (2000) Peng, Y; Zhang, Q; Arora, S; Keenan, SM; Kortagere, S; Wannemacher, KM; Howells, RD; Welsh, WJ Novel delta opioid receptor agonists exhibit differential stimulation of signaling pathways. Bioorg Med Chem 17: 6442 -50 (2009) Raynor, K; Kong, H; Chen, Y; Yasuda, K; Yu, L; Bell, GI; Reisine, T Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors. Mol Pharmacol 45: 330 -4 (1994) Clayson, J; Jales, A; Tyacke, RJ; Hudson, AL; Nutt, DJ; Lewis, JW; Husbands, SM Selective delta-opioid receptor ligands: potential PET ligands based on naltrindole. Bioorg Med Chem Lett 11: 939 -43 (2001) De Lucca, GV Synthesis and evaluation of delta lactams as nonpeptide HIV-protease inhibitors Bioorg Med Chem Lett 7: 501 -504 (1997) Kadayat, TM; Shrestha, A; Jeon, YH; An, H; Kim, J; Cho, SJ; Chin, J Targeting Peroxisome Proliferator-Activated Receptor Delta (PPARδ): A Medicinal Chemistry Perspective. J Med Chem 63: 10109 -10134 (2020) Coop, A; Jacobson, AE The LMC delta opioid recognition pharmacophore: comparison of SNC80 and oxymorphindole. Bioorg Med Chem Lett 9: 357 -62 (1999) Reeves, EK; Hoffman, EP; Nagaraju, K; Damsker, JM; McCall, JM VBP15: preclinical characterization of a novel anti-inflammatory delta 9,11 steroid. Bioorg Med Chem 21: 2241 -9 (2013) Portoghese, PS; Farouz-Grant, F; Sultana, M; Takemori, AE 7'-Substituted amino acid conjugates of naltrindole. Hydrophilic groups as determinants of selective antagonism of delta 1 opioid receptor-mediated antinociception in mice. J Med Chem 38: 402 -7 (1995) Maeda, DY; Berman, F; Murray, TF; Aldrich, JV Synthesis and evaluation of isothiocyanate-containing derivatives of the delta-opioid receptor antagonist Tyr-Tic-Phe-Phe (TIPP) as potential affinity labels for delta-opioid receptors. J Med Chem 43: 5044 -9 (2001) Lamar, J; Hu, J; Bueno, AB; Yang, HC; Guo, D; Copp, JD; McGee, J; Gitter, B; Timm, D; May, P; McCarthy, J; Chen, SH Phe*-Ala-based pentapeptide mimetics are BACE inhibitors: P2 and P3 SAR. Bioorg Med Chem Lett 14: 239 -43 (2003) Adams, AD; Yuen, W; Hu, Z; Santini, C; Jones, AB; MacNaul, KL; Berger, JP; Doebber, TW; Moller, DE Amphipathic 3-phenyl-7-propylbenzisoxazoles; human pPaR gamma, delta and alpha agonists. Bioorg Med Chem Lett 13: 931 -5 (2003) Hruby, VJ; Bartosz-Bechowski, H; Davis, P; Slaninova, J; Zalewska, T; Stropova, D; Porreca, F; Yamamura, HI Cyclic enkephalin analogues with exceptional potency and selectivity for delta-opioid receptors. J Med Chem 40: 3957 -62 (1998) Gonzalez, IC; Lamar, J; Iradier, F; Xu, Y; Winneroski, LL; York, J; Yumibe, N; Zink, R; Montrose-Rafizadeh, C; Etgen, GJ; Broderick, CL; Oldham, BA; Mantlo, N Design and synthesis of a novel class of dual PPARgamma/delta agonists. Bioorg Med Chem Lett 17: 1052 -5 (2007) Nagase, H; Osa, Y; Nemoto, T; Fujii, H; Imai, M; Nakamura, T; Kanemasa, T; Kato, A; Gouda, H; Hirono, S Design and synthesis of novel delta opioid receptor agonists and their pharmacologies. Bioorg Med Chem Lett 19: 2792 -5 (2009) Portoghese, PS; Sultana, M; Takemori, AE Design of peptidomimetic delta opioid receptor antagonists using the message-address concept. J Med Chem 33: 1714 -20 (1990) Pasquinucci, L; Turnaturi, R; Prezzavento, O; Arena, E; Aricò, G; Georgoussi, Z; Parenti, R; Cantarella, G; Parenti, C Development of novel LP1-based analogues with enhanced delta opioid receptor profile. Bioorg Med Chem 25: 4745 -4752 (2017) Hoegenauer, K; Soldermann, N; Stauffer, F; Furet, P; Graveleau, N; Smith, AB; Hebach, C; Hollingworth, GJ; Lewis, I; Gutmann, S; Rummel, G; Knapp, M; Wolf, RM; Blanz, J; Feifel, R; Burkhart, C; Zécri, F Discovery and Pharmacological Characterization of Novel Quinazoline-Based PI3K Delta-Selective Inhibitors. ACS Med Chem Lett 7: 762 -7 (2016) Kumar, V; Murray, TF; Aldrich, JV Extended TIP(P) analogues as precursors for labeled delta-opioid receptor ligands. J Med Chem 43: 5050 -4 (2001) Kim, HM; Hong, SH; Kim, MS; Lee, CW; Kang, JS; Lee, K; Park, SK; Han, JW; Lee, HY; Choi, Y; Kwon, HJ; Han, G Modification of cap group in delta-lactam-based histone deacetylase (HDAC) inhibitors. Bioorg Med Chem Lett 17: 6234 -8 (2007) Hayashida, K; Hirayama, S; Iwai, T; Watanabe, Y; Takahashi, T; Sakai, J; Nakata, E; Yamakawa, T; Fujii, H; Nagase, H Novel delta opioid receptor agonists with oxazatricyclodecane structure showing potent agonistic activities. Bioorg Med Chem Lett 27: 2742 -2745 (2017) Ban, S; Ueda, Y; Ohashi, M; Matsuno, K; Ikeda, M; Kato, N; Miyachi, H Peroxisome proliferator-activated receptor delta antagonists inhibit hepatitis C virus RNA replication. Bioorg Med Chem Lett 23: 4774 -8 (2013) Myatt, JW; Healy, MP; Bravi, GS; Billinton, A; Johnson, CN; Matthews, KL; Jandu, KS; Meng, W; Hersey, A; Livermore, DG; Douault, CB; Witherington, J; Bit, RA; Rowedder, JE; Brown, JD; Clayton, NM Pyrazolopyridazine alpha-2-delta-1 ligands for the treatment of neuropathic pain. Bioorg Med Chem Lett 20: 4683 -8 (2010) Lachance, N; Leclerc, J; Li, CS; Moradei, OM Spiro compounds useful as inhibitors of stearoyl-coenzyme A delta-9 desaturase US Patent US9168248 (2015) Li, Y; Combs, AP; Yue, EW; Mei, S; Douty, B Use of pyrazolopyrimidine derivatives for the treatment of PI3K-delta related disorders US Patent US9932341 (2018) Griffin, AM; Brown, W; Walpole, C; Coupal, M; Adam, L; Gosselin, M; Salois, D; Morin, PE; Roumi, M Delta agonist hydroxy bioisosteres: the discovery of 3-((1-benzylpiperidin-4-yl){4-[(diethylamino)carbonyl]phenyl}amino)benzamide with improved delta agonist activity and in vitro metabolic stability. Bioorg Med Chem Lett 19: 5999 -6003 (2009)
Jadhav, PK; Ala, P; Woerner, FJ; Chang, CH; Garber, SS; Anton, ED; Bacheler, LT J Med Chem 40: 181 -91 (1997) Sparks, RB; Polam, P; Zhu, W; Crawley, ML; Takvorian, A; McLaughlin, E; Wei, M; Ala, PJ; Gonneville, L; Taylor, N; Li, Y; Wynn, R; Burn, TC; Liu, PC; Combs, AP Bioorg Med Chem Lett 17: 736 -40 (2007)
ChEMBL_2475264 Inhibition of recombinant human full-length ADAMTS7 truncated before the C-terminal PLAC domain using FAM-Glu-Ala-Ala-Ala-Arg-Ala-Glu-Ala-Ala-Ala-Lys-TAMRA as substrate measured after 24 hrs by FRET assay ChEMBL_1796486 (CHEMBL4268603) Inhibition of delta-5 fatty acid desaturase (unknown origin) ChEMBL_158224 (CHEMBL764241) Inhibitory activity against porcine pancreatic elastase using Suc-Ala-Ala-Ala-pNA (416 uM) as substrate ChEBML_64137 Tested in vitro for its inhibitory effect against Elastase using Suc-Ala--Ala-Pro-Ala-pNA as substrate ChEMBL_676024 (CHEMBL1272962) Inhibition of Delta(5) fatty acid desaturase in human HepG2 cells ChEMBL_147169 (CHEMBL754468) In vitro binding affinity to Opioid receptor delta 1 in rat brain membranes by [3H]DADLE (Tyr-D-Ala-Gly-Phe-D-Leu) displacement. ChEMBL_1357228 (CHEMBL3284360) Noncompetitive inhibition of human granulocyte elastase using Ac-Ala-Ala-Pro-Ala-p-nitroanilide as substrate by Dixon plot analysis ChEMBL_63981 (CHEMBL677607) In vitro inhibition constant (Ki) against human leukocyte elastase (HLE-catalyzed hydrolysis of MeO-Suc-Ala-Ala-Pro-Ala-pNA) ChEBML_153862 In vitro activation of human peroxisome proliferator activated receptor delta (PPAR delta) ChEMBL_476919 (CHEMBL924570) Inhibition of mouse ZMPSTE24 expressed n delta ste24 delta rce1 yeast ChEMBL_676023 (CHEMBL1272961) Inhibition of rat Delta(5) fatty acid desaturase by cell based assay ChEMBL_676025 (CHEMBL1272963) Inhibition of Delta(5) fatty acid desaturase in freshly isolated rat hepatocytes Inhibition Assay Inhibition of D-Ala-D-Ala adding enzyme (MurF) from Streptococcus pneumoniase. ChEBML_153488 In vitro transcription activation on human peroxisome proliferator activated receptor-delta (PPAR delta) ChEBML_154031 In vitro binding affinity towards human peroxisome proliferator activated receptor delta (PPAR delta) ChEBML_154546 In vitro binding affinity against human PPAR delta (peroxisome proliferator-activated delta receptor) ChEMBL_1347909 (CHEMBL3267446) Inhibition of recombinant human legumain using Z-Ala-Ala-Asn-AMC fluorogenic substrate ChEBML_63804 Inhibitory concentration required against Human Leukocyte Elastase (HLE) for 50% reduction in rate of hydrolysis of (suc-Ala-Ala-Pro-Ala-p-NA) peptide ChEMBL_153880 (CHEMBL759402) Displacement of PPAR-alpha/delta agonist from human Peroxisome proliferator activated receptor delta ChEMBL_154031 (CHEMBL759301) In vitro binding affinity towards human peroxisome proliferator activated receptor delta (PPAR delta) ChEMBL_154546 (CHEMBL760265) In vitro binding affinity against human PPAR delta (peroxisome proliferator-activated delta receptor) ChEBML_49461 Inhibitory activity against chymotrypsin using Suc-Ala-Ala-Pro-Phe-pNA (416 uM) as substrate ChEBML_154542 Agonist activity against PPAR delta ChEMBL_2517129 Inhibition of human PKC delta ChEMBL_328558 (CHEMBL869429) Activity against PPAR-delta ChEMBL_364829 (CHEMBL870176) Inhibition of PPAR delta ChEMBL_458480 (CHEMBL942707) Inhibition of PKC delta ChEMBL_481050 (CHEMBL997490) Inhibition of PKC delta ChEMBL_509591 (CHEMBL1001352) Inhibition of PI3K delta ChEMBL_664527 (CHEMBL1260068) Inhibition of PI3K-delta ChEMBL_88197 (CHEMBL699807) Inhibition of human neutrophil elastase HNE, hydrolysis of MeO-Suc-Ala-Ala-Pro-Val-pNa ChEMBL_2220296 (CHEMBL5133630) Displacement of [3H]-(2-D-Ala)[Tyrosy1-3,5-]-DELTORPHIN II from Sprague-Dawley rat brain membrane delta opioid receptor incubated for 45 mins by liquid scintillation counting analysis ChEBML_145899 Inhibitory potency against delta Opioid receptor delta 1 in longitudinal muscle preparation of mouse vas deferens ChEMBL_63805 (CHEMBL676196) Inhibitory concentration required against Human Leukocyte Elastase (HLE) for 50% reduction in rate of hydrolysis of (suc-Ala-Ala-Pro-Ala-p-NA) peptide;compound was inactive Biochemical Assay Biochemical assay using PI3K delta. ChEBML_146436 Affinity for opioid receptor delta sites ChEBML_147334 Affinity towards opioid receptor delta 1 ChEBML_147340 Binding affinity for delta opioid receptor ChEBML_152992 Inhibition of protein kinase C delta ChEBML_153134 Inhibition of protein kinase C delta ChEBML_154038 Activity against murine PPAR delta receptor ChEBML_160767 Inhibition of Protein kinase C delta ChEBML_160778 Inhibition of protein kinase C delta. ChEBML_160782 Inhibition of Protein kinase C delta ChEBML_160783 Inhibition of Protein kinase C delta ChEMBL_1349385 (CHEMBL3269975) Inhibition of human PPAR-delta ChEMBL_2267332 Inhibition of p110 delta (unknown origin) ChEMBL_2292638 Inhibition of PI3K-delta (unknown origin) ChEMBL_2333615 Inhibition of PI3K delta (unknown origin) ChEMBL_2517235 Inhibition of p110 delta (unknown origin) ChEMBL_2568861 Inhibition of CAMK1 delta (unknown origin) ChEMBL_321091 (CHEMBL883694) Effective concentration towards PPAR delta ChEMBL_346251 (CHEMBL861206) Inhibitory activity against PKC delta ChEMBL_655503 (CHEMBL1244547) Binding affinity to p38-delta ChEMBL_664311 (CHEMBL1259346) Inhibition of delta opioid receptor ChEMBL_445895 (CHEMBL896185) Displacement of [3H]emopamil from Delta-(8)-Delta-(7) sterol isomerase in guinea pig liver membrane ChEMBL_792212 (CHEMBL1930739) Displacement of [3H]-emopamil from delta(8)-delta(7) sterol isomerase in guinea pig liver membranes ChEMBL_1367181 Inhibition of human recombinant NEP using Suc-Ala-Ala-Phe-AMC as substrate after 30 mins by fluorimetry ChEMBL_2236620 (CHEMBL5150516) Inhibition of human neutrophil elastase using methoxysuccinyl-Ala-Ala-Pro-Val-pnitroanilide as substrate by spectrophotometric analysis ChEMBL_655591 (CHEMBL1244635) Inhibition of human cathepsin G using N-Suc-Ala-Ala-Phe-Pro-pNA substrate by calorimetric assay ChEMBL_819861 (CHEMBL2034575) Inhibition of cathepsin G using Suc-Ala-Ala-Pro-Phe-p-nitroanilide as substrate after 30 mins ChEMBL_145747 (CHEMBL752636) Effective concentration was measured towards delta opioid receptor using mouse vas deferens(MVD, delta) bioassay in vitro ChEMBL_147023 (CHEMBL753664) Binding affinity against delta Opioid receptor delta 1 using [3H]DADLE as radioligand in guinea pig brain ChEMBL_203193 (CHEMBL804438) Inhibition of [3H]-emopamil binding to Sterol delta 8-delta 7 isomerase in guinea pig liver membrane ChEBML_144794 In vitro inhibition of the human neutrophil elastase-catalyzed hydrolysis of the synthetic substrate Suc-Ala-Pro-Ala-MCA ChEMBL_1442820 (CHEMBL3376525) Inhibition of Pseudomonas aeruginosa pseudolysin using Abz-Ala-Gly-Leu-Ala-p-nitrobenzylamide as substrate after 15 mins ChEMBL_2131303 (CHEMBL4840818) Inhibition of human neutrophil elastase using methoxysuccinyl-Ala-Ala-Pro-Val-pNA as substrate incubated for 15 min ChEMBL_2243357 (CHEMBL5157567) Inhibition of human neutrophil elastase using methoxysuccinyl-Ala-Ala-Pro-Val-pNA as substrate incubated for 10 mins ChEMBL_63969 (CHEMBL677437) Inhibition of human neutrophil elastase-catalyzed hydrolysis of the synthetic substrate MeO-Suc-Ala-Ala-Pro-Val-pNa ChEMBL_754229 (CHEMBL1798873) Inhibition of human recombinant MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala-Dap(Dnp)-NH2 substrate ChEMBL_819862 (CHEMBL2034576) Inhibition of proteinase 3 using N-MeOSuc-Ala-Ala-Pro-Val-p-nitroanilide as substrate after 60 mins ChEMBL_86534 (CHEMBL699953) Inhibitory activity against human leukocyte elastase using MeO-Suc-Ala-Ala-Pro-Val-pNA (416 uM) as substrate ChEBML_145469 Antagonistic activity against Opioid receptor delta 1 ChEBML_146441 Receptor binding affinity towards opioid receptor delta ChEBML_146728 Binding affinity towards Opioid receptor delta 1 ChEBML_146780 Affinity against the Opioid receptor delta 1 ChEBML_147138 Binding affinity against Opioid receptor delta 1 ChEBML_152994 Binding affinity for protein kinase C delta ChEBML_153149 Inhibition of serine/threonine kinase(PKC-delta) ChEBML_153879 Binding affinity for human PPAR delta receptor ChEBML_160645 Inhibition of Human Protein kinase C delta ChEBML_160770 Inhibition of human Protein kinase C delta ChEBML_160772 Inhibition of human Protein kinase C delta ChEBML_1627839 Inhibition of CK1 delta/epsilon (unknown origin) ChEBML_221175 Inhibition of human p38 delta MAP kinase ChEBML_306113 In vitro binding affinity for PPAR-delta ChEMBL_145487 (CHEMBL752130) Binding affinity for delta opioid receptor ChEMBL_146580 (CHEMBL755069) Agonistic activity for opioid receptor delta ChEMBL_147340 (CHEMBL756185) Binding affinity for delta opioid receptor ChEMBL_152992 (CHEMBL759477) Inhibition of protein kinase C delta ChEMBL_152995 (CHEMBL873305) Binding affinity for PKC-delta C1b ChEMBL_153134 (CHEMBL759073) Inhibition of protein kinase C delta ChEMBL_153861 (CHEMBL762590) Transcriptional activation by human PPAR delta ChEMBL_1583673 (CHEMBL3815760) Inhibition of PI3K delta (unknown origin) ChEMBL_160640 (CHEMBL768250) Inhibition of protein kinase C delta ChEMBL_160642 (CHEMBL768252) Inhibition of Protein kinase C delta ChEMBL_160766 (CHEMBL766307) Inhibition of Protein kinase C delta ChEMBL_160782 (CHEMBL766471) Inhibition of Protein kinase C delta ChEMBL_1709775 (CHEMBL4119824) Inhibition of PI3K delta (unknown origin) ChEMBL_1769360 (CHEMBL4221472) Inhibition of human recombinant PI3K-delta ChEMBL_1897787 (CHEMBL4399822) Inhibition of PI3K delta (unknown origin) ChEMBL_2026874 (CHEMBL4681032) Agonist activity at human PPAR-delta ChEMBL_2067838 (CHEMBL4723091) Inhibition of PI3K-delta (unknown origin) ChEMBL_2093906 (CHEMBL4775169) Inhibition of PI3K delta (unknown origin) ChEMBL_2196813 (CHEMBL5109329) Inhibition of CK1 delta (unknown origin) ChEMBL_2218577 (CHEMBL5131911) Inhibition of PI3K delta (unknown origin) ChEMBL_2437093 Inhibition of delta opioid receptor (unknown origin) ChEMBL_305430 (CHEMBL830923) Inhibition of Protein kinase C delta ChEMBL_321092 (CHEMBL883695) Effective concentration against PPAR delta receptor ChEMBL_325674 (CHEMBL863228) Agonistic activity at delta opioid receptor ChEMBL_325927 (CHEMBL869397) Inhibition of human delta opioid receptor ChEMBL_329931 (CHEMBL868792) Binding affinity to Delta opioid receptor ChEMBL_339275 (CHEMBL867228) Binding affinity to human PPAR delta ChEMBL_366644 (CHEMBL864704) Binding affinity to delta opioid receptor ChEMBL_435942 (CHEMBL905347) Inhibition of human DNA polymerase delta ChEMBL_437131 (CHEMBL906528) Binding affinity to delta opioid receptor ChEMBL_459305 (CHEMBL926464) Binding affinity to delta opioid receptor ChEMBL_497293 (CHEMBL995855) Binding affinity to delta opioid receptor ChEMBL_556745 (CHEMBL959808) Binding affinity to delta opioid receptor ChEMBL_556766 (CHEMBL961464) Binding affinity at delta opioid receptor ChEMBL_589795 (CHEMBL1051418) Binding affinity to delta opioid receptor ChEMBL_598546 (CHEMBL1043538) Inhibition of delta-type opioid receptor ChEMBL_629560 (CHEMBL1120978) Binding affinity to delta opioid receptor ChEMBL_799949 (CHEMBL1941655) Binding affinity to delta opioid receptor ChEMBL_878857 (CHEMBL2184570) Inhibition of Casein kinase 1 delta ChEMBL_884329 (CHEMBL2210362) Binding affinity to delta opioid receptor ChEBML_147028 Binding affinity of Opioid receptor delta 1 by the displacement of delta-selective [3H]DSLET from brain membrane preparations. ChEBML_86533 Inhibitory activity against human leukocyte elastase using MeO-Suc-Ala-Ala-Pro-Val-pNA (416 uM) as substrate;No Inhibition ChEMBL_1338356 (CHEMBL3240092) Inhibition of recombinant cathepsin G (unknown origin) using Suc-Ala-Ala-Pro-Phe-AMC as substrate by spectrofluorometer analysis ChEMBL_1431796 (CHEMBL3385092) Inhibition of neutrophil elastase in human plasma using MeOSuc-Ala-Ala-Pro-Val-AMC as substrate by fluorescence assay ChEMBL_1517836 (CHEMBL3620527) Inhibition of human neutrophil elastase using suc-Ala-Pro-Ala-pNA as substrate after 30 mins by spectrophotometric analysis ChEMBL_1517854 (CHEMBL3620650) Inhibition of neutrophil elastase in human plasma using MeOSuc-Ala-Ala-Pro-Val-AMC as substrate by fluorescence assay ChEMBL_1669325 (CHEMBL4019213) Inhibition of AEP (unknown origin) using Cbz-Ala-Ala-Asn-AMC as substrate after 15 mins by fluorescence assay ChEMBL_216620 (CHEMBL819192) Binding constant alpha-chymotrypsin was determined by competitive inhibition assay with Suc-Ala-Ala-Pro-Phe-pNA as substrate ChEMBL_63975 (CHEMBL677601) Inhibition of Human Neutrophil Elastase-catalyzed hydrolysis of the synthetic substrate MeO-Suc-Ala-Ala-Pro-Val-p- nitroanilide. ChEMBL_772627 (CHEMBL1839713) Inhibition of human leukocyte elastase using MeOSuc-Ala-Ala-Pro-Val-para-nitroanilide chromogenic substrate after 10 mins spectrophotometrically ChEMBL_819860 (CHEMBL2034574) Inhibition of human neutrophil elastase using chromogenic substrate (N-MeOSuc-Ala-Ala-Pro-Val-p-nitroanilide after 120 mins ChEMBL_992742 (CHEMBL2443644) Inhibition of bovine alpha-chymotrypsin using N-succinyl-Ala-Ala-Pro-Phe-p-NA as substrate by chromogenic assay ChEMBL_798084 (CHEMBL1943139) Inhibition of human delta-5 desaturase activity in human HepG2 cells using [1-14C]-stearic acid tracer ChEMBL_798085 (CHEMBL1943140) Inhibition of human delta-6 desaturase activity in human HepG2 cells using [1-14C]-stearic acid tracer ChEMBL_2034047 (CHEMBL4688205) Inhibition of GST-tagged Pin1 (unknown origin) using Suc-Ala-pSer-Pro-Phe-pNA, Suc-Ala-Glu-Pro-Phe-pNA or Suc-Ala-Ala-Pro-Phe-pNA as substrate preincubated with enzyme for 0.5 to 2 hrs followed by substrate addition by chymotrypsin coupled assay ChEMBL_306349 (CHEMBL828168) In vitro inhibitory concentration against human casein kinase 1 delta (CK1 delta) by using [gamma-33P]-ATP] as radioligand ChEMBL_1289379 (CHEMBL3116711) Inhibition of Streptococcus pneumoniae MurF ligase using D-Ala-D-Ala as substrate after 15 mins by malachite green assay ChEMBL_1431795 (CHEMBL3385091) Inhibition of human neutrophil elastase using MeOSuc-Ala-Ala-Pro-Val-AMC as substrate after 15 mins by fluorescence assay ChEMBL_1729324 (CHEMBL4144602) Inhibition of human neutrophil elastase using N-Methoxysuccinyl-Ala-Ala-Pro-Val-p-nitroanilid as substrate measured after 1 hr ChEMBL_2292359 Inhibition of recombinant HIV1 Protease using His-Lys-Ala-Arg-Val-Leu-(pNO2-Phe)-Glu-Ala-Nle-SerNH2 peptide as substrate ChEMBL_2455722 Inhibition of human leukocyte elastase using MeOSuc-Ala-Ala-Pro-Val-pNA as substrate measured for 10 mins by spectrophotometric analysis ChEMBL_49466 (CHEMBL657110) Concentration required to inhibit enzymatic cleavage of the chromogenic substrate (Suc-Ala-Ala-Pro-Phe-pNA) for chymotrypsin in vitro. ChEMBL_63977 (CHEMBL677603) In vitro inhibition of human leukocyte elastase mediated hydrolysis of the synthetic substrate MeO-Suc-Ala-Ala-Pro-Val-pNA ChEMBL_797391 (CHEMBL1942967) Inhibition of MMP1 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis ChEMBL_797392 (CHEMBL1942968) Inhibition of MMP3 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis ChEMBL_797393 (CHEMBL1943056) Inhibition of MMP19 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis ChEMBL_798829 (CHEMBL1943705) Inhibition of MMP2 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis ChEMBL_798833 (CHEMBL1943709) Inhibition of MMP9 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis ChEMBL_798834 (CHEMBL1943710) Inhibition of MMP12 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis ChEMBL_798835 (CHEMBL1943711) Inhibition of MMP14 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis ChEMBL_86533 (CHEMBL699952) Inhibitory activity against human leukocyte elastase using MeO-Suc-Ala-Ala-Pro-Val-pNA (416 uM) as substrate;No Inhibition ChEMBL_899483 (CHEMBL3047383) Inhibition of Human immunodeficiency virus 1 protease using Lys-Ala-Arg-Val-Leu-Phe(NO2)-Glu-Ala-Met as substrate ChEMBL_992740 (CHEMBL2443642) Inhibition of human neutrophil leukocyte elastase using N-(methoxysuccinyl)-Ala-Ala-Pro-Val-p-NA as substrate by chromogenic assay ChEBML_139552 Activation of murine PPAR delta ligand binding domain ChEBML_147338 Binding affinity to cloned Opioid receptor delta 1 ChEBML_1552634 Binding affinity at delta opioid receptor (unknown origin) ChEBML_1651394 Binding affinity to delta opioid receptor (unknown origin) ChEMBL_145056 (CHEMBL753990) Agonist activity for Opioid receptor delta 1 ChEMBL_1452453 (CHEMBL3362477) Binding affinity to human delta opioid receptor ChEMBL_145311 (CHEMBL751917) Agonistic activity towards Opioid receptor delta 1 ChEMBL_1453328 (CHEMBL3366612) Binding affinity to human delta opioid receptor ChEMBL_145765 (CHEMBL752783) Binding affinity against Opioid receptor delta 1 ChEMBL_146728 (CHEMBL753266) Binding affinity towards Opioid receptor delta 1 ChEMBL_147335 (CHEMBL756180) Binding affinity against Opioid receptor delta 1 ChEMBL_152993 (CHEMBL759478) Binding affinity for Protein kinase C delta ChEMBL_153879 (CHEMBL759401) Binding affinity for human PPAR delta receptor ChEMBL_1569809 (CHEMBL3792248) Agonist activity at PPAR delta (unknown origin) ChEMBL_160645 (CHEMBL769333) Inhibition of Human Protein kinase C delta ChEMBL_160775 (CHEMBL766315) Inhibition of human Protein kinase C delta ChEMBL_160781 (CHEMBL766321) Inhibition of Protein kinase C delta (PKCdelta) ChEMBL_1627839 (CHEMBL3870424) Inhibition of CK1 delta/epsilon (unknown origin) ChEMBL_220890 (CHEMBL824645) In vitro transcriptional activation of hPPAR delta ChEMBL_2494534 Binding affinity to delta-opioid receptor (unknown origin) ChEMBL_302679 (CHEMBL839442) Binding affinity for human Delta opioid receptor ChEMBL_320775 (CHEMBL884730) Affinity towards cloned Opioid receptor delta 1 ChEMBL_499366 (CHEMBL1015818) Inhibition of rat microsomal delta-(9)-desaturase ChEMBL_512434 (CHEMBL980775) Displacement of radioligand from delta opioid receptor ChEMBL_531811 (CHEMBL991523) Antagonist activity at protein kinase C delta ChEMBL_562450 (CHEMBL1010953) Inhibition of rat microsomal Delta-6-desaturase ChEMBL_562700 (CHEMBL1012735) Inhibition of rat microsomal Delta-5-desaturase ChEMBL_664949 (CHEMBL1259781) Binding affinity to human delta opioid receptor ChEMBL_771176 (CHEMBL1837093) Agonist activity at delta-type opioid receptor ChEMBL_774372 (CHEMBL1908589) Binding constant for p38-delta kinase domain ChEMBL_856830 (CHEMBL2163095) Binding affinity to rat delta opioid receptor ChEMBL_978822 (CHEMBL2423424) Inhibition of PI-3K delta (unknown origin) ChEMBL_1463425 (CHEMBL3399762) Inhibition of Pr3 (unknown origin) using t-butyloxycarbonyl-Ala-Ala-Nva-thiobenzyl ester as substrate measured for 180 mins by spectrophotometry ChEMBL_1517835 (CHEMBL3620526) Inhibition of human neutrophil elastase using MeO-Succ-Ala-Ala-Pro-Val-AMC as substrate after 30 mins by fluorescence assay ChEMBL_1987703 (CHEMBL4621250) Inhibition of Pseudomonas aeruginosa LasB using aminobenzoyl-Ala-Gly-Leu-Ala-p-nitro-benzyl-amide as fluorogenic substrate by fluorimetric assay ChEMBL_2367826 Inhibition of AEP in mouse kidney lysate using Cbz-Ala-Ala-Asn-AMC as substrate incubated for 30 mins by fluorescence assay ChEMBL_972955 (CHEMBL2412036) Inhibition of human pancreatic chymotrypsin using Suc-Ala-Ala-Pro-7-amino-4-methylcoumarin as substrate by fluorescence microplate reader analysis ChEMBL_147065 (CHEMBL754885) In vitro radioligand binding assay, for inhibition of [3H]DADLE (Tyr-D-Ala-Gly-Phe-D-Leu) binding to Opioid receptor delta 1, in rat brain membranes at highest concentration of 1700 nM tested ChEMBL_145489 (CHEMBL752132) Binding affinity towards recombinant humanOpioid receptor delta 1 transfected in to CHO cells for the displacement of [3H]Cl-DPDPE (delta) ChEBML_197807 Compound was tested in vitro for its ability to inhibit serine protease chymotrypsin using suc-Ala-Ala-Pro-Phe-p-nitroanilide as substrate ChEMBL_1278123 (CHEMBL3095811) Inhibition of human proteinase 3 using N-MeOSuc-Ala-Ala-Pro-Val-p-nitroanilide as substrate measured for 30 mins by spectrophotometry ChEMBL_1463426 (CHEMBL3399763) Inhibition of human cathepsin G using N-succinyl-Ala-Ala-Pro-Phe-p-nitroanilide as substrate measured for 180 mins by spectrophotometry ChEMBL_1552610 (CHEMBL3762415) Inhibition of TACE (unknown origin) using Mca-Pro-Leu-Ala-Gln-Ala-Val-Dpa-Arg-Ser-Ser-Ser-Arg-NH2 as substrate ChEMBL_1772760 (CHEMBL4229752) Inhibition of bovine alpha-chymotrypsin using succinyl Ala-Ala-Pro-Phe-p-nitroanilide as substrate after 1 hr by Dixon plot analysis ChEMBL_2296493 Inhibition of Pseudomonas aeruginosa LasB elastase using aminobenzoyl-Ala-Gly-Leu-Ala-p-nitro-benzyl-amide as substrate b microtiter-based fluorimetric assay ChEMBL_2496625 Inhibition of bovine alpha-chymotrypsin using N-succinyl-Ala-Ala-Pro-Phe p-nitroanilide as substrate incubated for 10 mins by chromogenic assay ChEMBL_45348 (CHEMBL884103) Concentration required to inhibit enzymatic cleavage of the chromogenic substrate (MeO-Suc-Ala-Ala-Pro-Met-pNA) for cathepsin G in vitro. ChEMBL_45530 (CHEMBL660233) Inhibition of cathepsin G at pH 7.5 in HEPES buffer containing 200 mM NaCl with substrate Suc-Ala-Ala-Pro-Phe-pNA. ChEMBL_63653 (CHEMBL675540) Concentration required to inhibit enzymatic cleavage of the chromogenic substrate (MeO-Suc-Ala-Ala-Pro-Val-pNA) for sputum elastase in vitro. ChEMBL_63984 (CHEMBL677610) In vitro inhibitory activity against human leukocyte elastase (HLE) mediated hydrolysis of the synthetic substrate MeO-Suc-Ala-Ala-Pro-Val-pNA ChEMBL_63986 (CHEMBL677612) In vitro inhibitory activity against human neutrophil elastase (HNE) catalyzed hydrolysis of the synthetic substrate MeO-Suc-Ala- Ala-Pro-Val-pN ChEMBL_63989 (CHEMBL673099) In vitro inhibitory activity against human neutrophil elastase (HNE-catalyzed hydrolysis of the synthetic substrate MeO-Suc-Ala- Ala-Pro-Val-pN) ChEMBL_798828 (CHEMBL1943704) Inhibition of recombinant human MMP13 using Mca-Pro-cyclohexyl-Ala-Gly-Nva-His-Ala- Dap(Dnp)-NH2 as substrate by fluorometric analysis ChEMBL_805028 (CHEMBL1952889) Inhibition of mouse recombinant legumain using Cbz-Ala-Ala-Asn-AMC as substrate measured every 30 secs for 2.5 hrs by fluorimetry ChEBML_146444 Compound was evaluated for the opioid receptor delta affinity ChEBML_147336 Displacement of [3H]DADLE from Opioid receptor delta 1 ChEBML_147337 Binding affinity for Opioid receptor delta 1 was determined ChEBML_147341 In vitro binding affinity towards opioid receptor delta 1 ChEBML_152996 Binding affinity for human recombinant protein kinase C delta ChEBML_160790 Displacement of [3H]PDBu from Protein kinase C delta ChEBML_160946 Binding affinity for protein kinase C Delta-C1B domain ChEBML_53586 Ability to displace [3H]DADL from delta opioid receptor ChEMBL_1283875 (CHEMBL3106326) Binding affinity to delta opioid receptor (unknown origin) ChEMBL_1339709 (CHEMBL3243304) Binding affinity to delta opioid receptor (unknown origin) ChEMBL_145325 (CHEMBL750413) Binding affinity at cloned human delta-opioid receptor ChEMBL_146322 (CHEMBL757531) Displacement of [3H]DADLE at delta-opioid receptor ChEMBL_146328 (CHEMBL757536) Binding affinity was measured on delta opioid receptor ChEMBL_146337 (CHEMBL753786) Evaluated for the binding affinity at delta receptor ChEMBL_147343 (CHEMBL756188) Opioid receptor delta 1 agonist activity was determined ChEMBL_1504510 (CHEMBL3590952) Antagonist activity against delta opioid receptor (unknown origin) ChEMBL_1504517 (CHEMBL3590959) Binding affinity to delta opioid receptor (unknown origin) ChEMBL_1507469 (CHEMBL3599494) Binding affinity to delta opioid receptor (unknown origin) ChEMBL_1513296 (CHEMBL3611102) Inhibition of liver delta-5 desaturase (unknown origin) ChEMBL_153871 (CHEMBL759393) Maximum transcriptional activation of human PPAR delta receptor ChEMBL_1539083 (CHEMBL3738444) Binding affinity to delta opioid receptor (unknown origin) ChEMBL_1552634 (CHEMBL3762573) Binding affinity at delta opioid receptor (unknown origin) ChEMBL_160773 (CHEMBL766313) Binding affinity for human Protein kinase C delta ChEMBL_1869949 (CHEMBL4371116) Binding affinity to delta opioid receptor (unknown origin) ChEMBL_2128136 (CHEMBL4837565) Binding affinity to delta-opioid receptor (unknown origin) ChEMBL_2149257 (CHEMBL5033655) Inhibition of CK-1 delta/epsilon (unknown origin) ChEMBL_2239505 (CHEMBL5153401) Inhibition of human PI3K-delta by HTRF assay ChEMBL_320734 (CHEMBL881207) Binding affinity towards peroxisome proliferator activated receptor delta ChEMBL_327761 (CHEMBL870569) Displacement of [3H]DPDPE from delta opioid receptor ChEMBL_339278 (CHEMBL867231) Transactivation by human PPAR delta in COS1 cells ChEMBL_379861 (CHEMBL864849) Displacement of [3H]DPDE from delta opioid receptor ChEMBL_401406 (CHEMBL870425) Activity at delta opioid receptor by MVD assay ChEMBL_439695 (CHEMBL888806) Displacement of [3H]DADLE from delta opioid receptor ChEMBL_466558 (CHEMBL935650) Displacement of [3H]DADLE from opioid delta receptor ChEMBL_486183 (CHEMBL1013977) Displacement of [3H]DPDPE from delta opioid receptor ChEMBL_525305 (CHEMBL968094) Displacement of [125]OXY from delta opioid receptor ChEMBL_658577 (CHEMBL1247910) Binding affinity to human recombinant opiate delta receptor ChEMBL_745569 (CHEMBL1775886) Displacement of [3H]DADLE from delta opioid receptor ChEMBL_963011 (CHEMBL2390019) Binding affinity to delta opioid receptor (unknown origin) ChEMBL_968736 (CHEMBL2399172) Binding affinity to delta opioid receptor (unknown origin) ChEMBL_1541440 (CHEMBL3743608) Inhibition of recombinant Brugia malayi DPY-31 astacin domain expressed in Escherichia coli using Suc-Ala-Ala-Ala-pNA as substrate preincubated for 3 hrs followed by substrate addition measured after 3 hrs by microplate reader assay ChEMBL_1541441 (CHEMBL3743609) Inhibition of recombinant Teladorsagia circumcincta DPY-31 astacin domain expressed in Escherichia coli using Suc-Ala-Ala-Ala-pNA as substrate preincubated for 3 hrs followed by substrate addition measured after 3 hrs by microplate reader assay ChEMBL_145488 (CHEMBL752131) Binding affinity towards recombinant human Opioid receptor delta 1 transfected in to CHO cells for the displacement of [3H]Cl-DPDPE (delta) ChEMBL_1369222 (CHEMBL3300757) Inhibition of cathepsin D in human liver using Lys-Lys-Pro-Ala-Glu-Phe-Phe-Ala-Leu-Lys as substrate by spectrofluorometric analysis ChEMBL_1540559 (CHEMBL3744013) Inhibition of recombinant human legumain using Z-Ala-Ala-Asn-MCA substrate measured every 2 mins for 60 mins by microplate reader analysis ChEMBL_1793167 (CHEMBL4265086) Competitive inhibition of human neutrophil elastase using N-methylsuccinyl-Ala-Ala-Pro-Val-7-amino-4-methylcoumarin as substrate by Dixon plot analysis ChEMBL_1827395 (CHEMBL4327269) Inhibition of cathepsin G in human neutrophils using Suc-Ala-Ala-Pro-Phe-(p-nitroanilide) as substrate for 15 mins by spectrophotometric method ChEMBL_1827396 (CHEMBL4327270) Inhibition of chymase in human mast cells using Suc-Ala-Ala-Pro-Phe-(p-nitroanilide) as substrate for 15 mins by spectrophotometric method ChEMBL_1904295 (CHEMBL4406517) Inhibition of rat kidney NEP using glutaryl-Ala-Ala-beta-naphthylamide as substrate preincubated with enzyme for 15 mins followed by substrate addition ChEMBL_775452 (CHEMBL1913027) Inhibition of PPIase activity of human recombinant cyclophilin-A using succinyl-Ala-Ala-Pro-Phe-4-nitroanilide as substrate by protease coupled assay Elastase Activity Assay The elastase inhibitor activity was examined using N-succinyl-Ala-Ala-Ala-pnitroanilide (STANA) as the substrate and by the measuring of the release of p-nitroaniline at 410 nm [James et al., Biochemistry, 35:9090-9096]. ChEMBL_955747 (CHEMBL2379524) Inhibition of Clostridium botulinum BoNT/A light chain (1 to 429 amino acid) using Abz-Thr-dArg-Ile-Asp-Glu-Ala-Asn-Gln-Arg-Ala-Thr-Lys-Nle-Lys(Dnp)-NH2 as substrate after 10 mins by FRET assay ChEMBL_147288 (CHEMBL755876) The ability of compound to inhibit [35S]GTP-delta-S binding in guinea pig caudate stimulated by SNC80 (Opioid receptor delta 1) antagonist ChEMBL_909060 (CHEMBL3049784) Inhibition of Zea mays (maize) microsomal delta 8,14-steroid 14-reductase using delta 8,14-cholestadienol as substrate after 90 min by GC analysis ChEMBL_1365623 (CHEMBL3297470) Inhibition of human PBGS using 5-ALA as substrate ChEMBL_1517831 (CHEMBL3620522) Inhibition of neutrophil elastase in human whole blood using MeO-Succ-Ala-Ala-Pro-Val-pNA as substrate after 30 mins by colorimetric analysis ChEMBL_973500 (CHEMBL2410674) Inhibition of human recombinant MMP-14 using Mca-Pro-Leu-Ala-Nva-Dpa-Ala-Arg-NH2 as substrate after 20 hrs by fluorescence assay ChEBML_146726 Binding affinity against delta opioid receptor from calf frontal cortex. ChEBML_146889 Ability to displace [3H]-deltorphin II from delta opioid receptor ChEBML_153884 In vitro binding affinity for human PPAR delta in SPA ChEBML_1573819 Inhibition of delta opioid receptor (unknown origin) by PDSP assay ChEBML_305941 Inhibitory concentration against Delta opioid receptor of mouse vas deferens ChEMBL_1351518 (CHEMBL3268113) Binding affinity to PKC-delta C1B domain (unknown origin) ChEMBL_145192 (CHEMBL754437) Binding affinity towards delta-opioid receptor from CHO cells ChEMBL_145321 (CHEMBL750409) Binding affinity against delta opiate receptor using [3H]DPDPE ChEMBL_145323 (CHEMBL750411) Inhibition of ligand binding to human delta opioid receptor. ChEMBL_145340 (CHEMBL750575) Inverse agonist potency at cloned human delta-opioid receptor ChEMBL_1453623 (CHEMBL3363472) Inhibition of CK1-delta (unknown origin) by radiometric assay ChEMBL_145631 (CHEMBL753544) Displacement of [3H]-naloxone from Opioid receptor delta 1 ChEMBL_145904 (CHEMBL750393) Opioid receptor delta 1 agonism in mouse vas deferens ChEMBL_146340 (CHEMBL753789) Inhibition against delta-opioid receptor using [3H]DPDPE radioligand. ChEMBL_146437 (CHEMBL757334) Binding affinity was measured on opioid receptor delta sites. ChEMBL_146762 (CHEMBL755206) Binding affinity for rat brain Opioid receptor delta 1 ChEMBL_147329 (CHEMBL756174) Binding affinity towards Opioid receptor delta 1 was evaluated ChEMBL_147339 (CHEMBL756184) Binding affinity towards Opioid receptor delta 1 was determined ChEMBL_1516517 (CHEMBL3619868) Displacement of [3H]DPDPE from human delta opiod receptor ChEMBL_1517222 (CHEMBL3620206) Displacement of [3H] DAMGO from human delta opioid receptor ChEMBL_1549028 (CHEMBL3756647) Displacement of [3H]DPDPE from human delta opioid receptor ChEMBL_1589945 (CHEMBL3830935) Agonist activity at human PPAR-delta by transactivation assay ChEMBL_160793 (CHEMBL766604) Binding affinity for Protein kinase C delta C1a domain ChEMBL_160938 (CHEMBL769101) Binding affinity for Protein kinase C delta C1b domain ChEMBL_160944 (CHEMBL769107) Binding affinity for protein kinase C Delta-C1A domain ChEMBL_160946 (CHEMBL769108) Binding affinity for protein kinase C Delta-C1B domain ChEMBL_1625828 (CHEMBL3868297) Inhibition of PI3K-delta (unknown origin) by KinaseGlo assay ChEMBL_1721385 (CHEMBL4136385) Binding affinity to delta-type opioid receptor (unknown origin) ChEMBL_1970503 (CHEMBL4603321) Inhibition of PI3K delta (unknown origin) by Adapta assay ChEMBL_2019879 (CHEMBL4673692) Inhibition of PI3K-delta (unknown origin) by HTRF assay ChEMBL_2033541 (CHEMBL4687699) Inhibition of delta-type opioid receptor receptor (unknown origin) ChEMBL_2538105 Inhibition of human p38-delta by discoverX kinome scan assay ChEMBL_302811 (CHEMBL839501) Binding affinity for delta opioid receptor of rat brain ChEMBL_302899 (CHEMBL830360) Inhibition of [3H]DPDPE binding to delta-Opioid receptor ChEMBL_304214 (CHEMBL829754) Effective concentration for human peroxisome proliferator-activated receptor delta ChEMBL_321371 (CHEMBL881515) Inhibitory concentration against mitogen-activated protein kinase p38-delta ChEMBL_327765 (CHEMBL871139) Activity at delta opioid receptor in mouse vas deferens ChEMBL_331786 (CHEMBL864669) Inhibitory activity against HCV delta 21 NS5b RNA polymerase ChEMBL_361576 (CHEMBL870153) Displacement of [125I]IOXY from human delta opioid receptor ChEMBL_401403 (CHEMBL855304) Displacement of [3H]DPDPE from human delta opioid receptor ChEMBL_449625 (CHEMBL898720) Displacement of [3H]deltorphin 2 from delta opioid receptor ChEMBL_499367 (CHEMBL1015819) Inhibition of delta-(9)-desaturase from human HepG2 cells ChEMBL_53586 (CHEMBL665474) Ability to displace [3H]DADL from delta opioid receptor ChEMBL_562452 (CHEMBL1010955) Inhibition of Delta-9-desaturase in human HepG2 cells ChEMBL_647571 (CHEMBL1217618) Displacement of [3H]DPDPE from human delta opioid receptor ChEMBL_750886 (CHEMBL1786331) Binding affinity to human recombinant iNOS delta 65 residue ChEMBL_805312 (CHEMBL1955205) Inhibition of delta-5 desaturase expressed in HepG2 cells ChEMBL_805313 (CHEMBL1955206) Inhibition of delta-6 desaturase expressed in HepG2 cells ChEMBL_839973 (CHEMBL2090369) Inhibition of PI3K delta by continuous TR-FRET assay ChEMBL_1825411 (CHEMBL4325175) Inhibition of human GSK3beta using biotinylated-aminohexyl-Ala-Ala-Ala-Lys-Arg-Arg-Glu-Ile-Leu-Ser-Arg-Arg-Pro-Ser(PO3)-Tyr-Arg-amide as substrate after 40 mins in presence of [gamma-32P]ATP by scintillation proximity assay ChEMBL_1825412 (CHEMBL4325176) Inhibition of human CDK2 using biotinylated-aminohexyl-Ala-Ala-Ala-Lys-Arg-Arg-Glu-Ile-Leu-Ser-Arg-Arg-Pro-Ser(PO3)-Tyr-Arg-amide as substrate after 40 mins in presence of [gamma-32P]ATP by scintillation proximity assay ChEMBL_1825413 (CHEMBL4325177) Inhibition of human CDK4 using biotinylated-aminohexyl-Ala-Ala-Ala-Lys-Arg-Arg-Glu-Ile-Leu-Ser-Arg-Arg-Pro-Ser(PO3)-Tyr-Arg-amide as substrate after 40 mins in presence of [gamma-32P]ATP by scintillation proximity assay ChEMBL_2349462 Inhibition of human 8His tagged AEP using Z-Ala-Ala-Asn-Rhl 10-(D-Pro) as fluorogenic substrate incubated for 30 mins by fluorescence based analysis ChEMBL_770450 (CHEMBL1833759) Inhibition of neutral endopeptidase in human fibroblasts homogenates using glutaryl-Ala-Ala-Phe-4-methoxy-2-naphtylamide as substrate after 1 hrs by fluorimetric assay ChEMBL_840308 (CHEMBL2091265) Inhibition of snake venom BaP1 using Abz-Ala-Gly-Leu-Ala-Nba as substrate incubated for 30 mins prior to substrate addition by fluorescence spectrophotometry ChEBML_147165 Compound was tested for the inhibition of [35S]GTP-gamma-S, binding in Guinea pig Caudate stimulated by the Opioid receptor delta 1 agonist Delta-SNC80 ChEMBL_1365592 (CHEMBL3297373) Inhibition of Pisum sativum PBGS using 5-ALA as substrate ChEMBL_2115925 (CHEMBL4824866) Inhibition of APN (unknown origin) using Ala-AMC as substrate ChEMBL_1298586 (CHEMBL3132373) Inhibition of HIV1 recombinant protease expressed in Escherichia coli using Abz-Ala-Arg-Val-Nle-Tyr(NO2)-Glu-Ala-Nle-NH2 as substrate by FRET assay ChEMBL_1542880 (CHEMBL3743215) Inhibition of CypA (unknown origin) assessed as peptidyl-prolyl cis-trans isomerase activity using N-succinyl-Ala-Ala-Pro-Phe-p-nitroanilide as substrate by spectrophotometry ChEMBL_1837839 (CHEMBL4337972) Inhibition of HIV1 protease expressed in Escherichia coli using Abz-Ala-Arg-Val-Nle-Tyr(NO2)-Glu-Ala-Nle-NH2 peptide as substrate by FRET assay ChEMBL_2233774 (CHEMBL5147546) Inhibition of recombinant human Asparagine endopeptidase preincubated for 5 mins followed by Z-Ala-Ala-Asn-AMC substrate addition measured after 2 hrs by microplate reader ChEMBL_2426275 Inhibition of Chymotrypsin (unknown origin) using N-Suc-Ala-Ala-Pro-Phe-pNA as chromogenic substrate incubated for 20 mins followed by substrate addition by spectrophotometric analysis ChEBML_146442 Compound was evaluated for the binding affinity to opioid receptor delta ChEBML_146451 In vitro opioid receptor delta mediated mouse vas deferens (MVD) assay ChEBML_146592 Displacement of [3H]DSLET from rat brain membrane opioid receptor delta ChEBML_146923 Binding affinity to delta opioid receptor was measured using [3H]DADLE ChEBML_160774 Displacement of [3H]-PDBu from human recombinant Protein kinase C delta ChEBML_160939 Displacement of [3H]PDBu from protein kinase C delta C1b domain ChEBML_217856 Compound was evaluated for the binding affinity to delta opioid receptor ChEBML_217860 Binding affinity against delta receptor with [3H][p-Cl-Phe4]-DPDPE ChEBML_302933 Binding affinity for isolated C1b domain of protein kinase C-delta ChEBML_53430 Binding affinity towards opioid Delta receptor using [3H]DADLE as radioligand ChEBML_53571 Binding affinity towards opioid Delta receptor using [3H]DADLE as radioligand ChEMBL_1335004 (CHEMBL3239391) Displacement of [3H]DPDPE from delta opioid receptor (unknown origin) ChEMBL_1353488 (CHEMBL3269824) Agonist activity at delta opioid receptor in mouse vas deferens ChEMBL_1361836 (CHEMBL3292772) Binding affinity to PDE-delta (unknown origin) by SPR analysis ChEMBL_1365290 (CHEMBL3292384) Displacement of [3H]DPDPE from delta-opioid receptor (unknown origin) ChEMBL_145341 (CHEMBL750576) Inverse agonist potency at cloned human opioid receptor delta 1 ChEMBL_145889 (CHEMBL754255) Inhibitory activity against Opioid receptor delta 1 using [3H]DPDPE ChEMBL_146339 (CHEMBL753788) Inhibition against Opioid receptor delta 1 using [3H]DPDPE radioligand. ChEMBL_147032 (CHEMBL753673) Inhibition of [3H]-DADLE binding to rat brain delta receptor ChEMBL_147342 (CHEMBL756187) Inhibition of [3H]- diprenorphine binding to Opioid receptor delta 1 ChEMBL_153884 (CHEMBL759406) In vitro binding affinity for human PPAR delta in SPA ChEMBL_1552794 (CHEMBL3760687) Agonist activity at delta-opioid receptor in mouse vas deferens ChEMBL_160768 (CHEMBL766309) Inhibitory concentration against recombinant human Protein kinase C delta isozyme ChEMBL_160791 (CHEMBL766602) Displacement of [3H]PDBu from recombinant Protein kinase C delta ChEMBL_162089 (CHEMBL767782) Inhibition of [3H]PDBu binding to PKC delta wild type ChEMBL_162558 (CHEMBL768500) Inhibition of [3H]PDBu binding to PKC delta wild type ChEMBL_1823727 (CHEMBL4323491) Displacement of [3H] diprenorphine from delta opioid receptor (unknown origin) ChEMBL_1906936 (CHEMBL4409294) Inhibition of delta opioid receptor (unknown origin) by MVD assay ChEMBL_216976 (CHEMBL822793) Functional potency for nAChR subtype Alpha1-beta1 delta gamma (torpedo) ChEMBL_2422155 Agonist activity at human PPAR delta by luciferase reporter gene assay ChEMBL_2538306 Inhibition of human PPAR-delta by Eurofins-CEREP pharmacology platform analysis ChEMBL_305706 (CHEMBL827221) In vitro inhibition of human Peroxisome proliferator activated receptor delta ChEMBL_306435 (CHEMBL828248) Mean inhibitory concentration against human peroxisome proliferator-activated receptor delta ChEMBL_325357 (CHEMBL861057) Functional bioactivity against delta opioid receptor in mouse vas deferens ChEMBL_326438 (CHEMBL867596) Agonistic activity at delta opioid receptor in mouse vas deferens ChEMBL_326603 (CHEMBL863384) Agonistic activity at delta opioid receptor in mouse vas deferens ChEMBL_328876 (CHEMBL859855) Displacement of [3H]DPDPE from cloned human delta opioid receptor ChEMBL_333515 (CHEMBL866454) Displacement of [3H]diprenorphine from human cloned delta opioid receptor ChEMBL_334062 (CHEMBL861271) Agonist activity at delta opioid receptor in mouse vas deferens ChEMBL_352179 (CHEMBL869659) Displacement of [3H]phorbol 12,13-dibutyrate from PKC delta-C1A ChEMBL_352180 (CHEMBL869660) Displacement of [3H]phorbol 12,13-dibutyrate from PKC delta-C1B ChEMBL_364004 (CHEMBL860182) Functional bioactivity against delta opioid receptor in mouse vas deferens ChEMBL_428453 (CHEMBL918954) Displacement of [3H]DSLET from rat brain delta opioid receptor ChEMBL_428456 (CHEMBL918957) Agonist activity at delta opioid receptor in mouse vas deferens ChEMBL_439348 (CHEMBL887341) Agonist activity at delta opioid receptor in mouse vas deferens ChEMBL_446659 (CHEMBL896954) Displacement of [3H]DPDPE from human cloned delta opioid receptor ChEMBL_447456 (CHEMBL896479) Displacement of [3H]DPDPE from cloned human delta opioid receptor ChEMBL_455040 (CHEMBL887069) Displacement of [3H]diprenorphine from human cloned delta opioid receptor ChEMBL_455045 (CHEMBL887074) Agonist activity at delta opioid receptor in mouse vas deferens ChEMBL_457568 (CHEMBL922768) Displacement of [3H]p-Cl-DPDPE from delta opioid receptor ChEMBL_477640 (CHEMBL928102) Agonist activity at delta opioid receptor in mouse vas deferens ChEMBL_543174 (CHEMBL1015122) Binding affinity to delta opioid receptor in rat brain membrane ChEMBL_607041 (CHEMBL1074669) Antagonist activity at delta opioid receptor by GTPgammaS bunding assay ChEMBL_615881 (CHEMBL1102715) Antagonist activity at delta opioid receptor in mouse vas deferens ChEMBL_647236 (CHEMBL1217377) Agonist activity at delta opioid receptor in mouse vas deference ChEMBL_665133 (CHEMBL1260396) Inhibition of [3H]PDBu binding to PKC delta C1A peptide ChEMBL_665134 (CHEMBL1260397) Inhibition of [3H]PDBu binding to PKC delta C1B peptide ChEMBL_749290 (CHEMBL1785225) Agonist activity at delta opioid receptor in mouse vas deference ChEMBL_876446 (CHEMBL2187198) Binding affinity to delta opioid receptor by radioligand binding assay ChEMBL_878565 (CHEMBL2188650) Agonist activity at delta opioid receptor in mouse vas deferens ChEMBL_882180 (CHEMBL2215453) Agonist activity at delta opioid receptor in mouse vas deferens ChEMBL_933960 (CHEMBL2317778) Inhibition of CK1-delta (unknown origin) in presence of ATP ChEMBL_959948 (CHEMBL2383890) Displacement of [3H]DADLE from delta opioid receptor (unknown origin) ChEMBL_969758 (CHEMBL2404100) Agonist activity at delta opioid receptor in mouse vas deferens ChEMBL_1523620 (CHEMBL3631551) Inhibition of recombinant human Neprilysin using Suc-Ala-Ala-Phe-AMC as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by fluorometry ChEMBL_1550089 (CHEMBL3756035) Inhibition of Bacillus thermoproteolyticus pseudolysin pretreated with compound for 15 mins followed by the addition of Abz-Ala-Gly-leu-Ala-p-nitrobenzalamide as substrate by spectrofluorometry ChEMBL_1747820 (CHEMBL4182330) Inhibition of recombinant human chymase pre-incubated for 10 mins before Suc-Ala-Ala-Pro-Phe-MCA substrate addition and measured after 10 mins by fluorescence assay ChEMBL_1841425 (CHEMBL4341724) Inhibition of recombinant human legumain using Z-Ala-Ala-Asn-AMC as substrate measured for every 2 mins for 60 mins by fluorescence-based microplate reader analysis ChEMBL_1880499 (CHEMBL4381893) Inhibition of human leukocyte elastase assessed as reduction in pNA release using chromogenic MeO-Suc-Ala-Ala-Pro-Val-pNA substrate measured over 10 mins by spectrophotometry ChEMBL_2303192 Displacement of [3H]-diprenorphine from KOR receptor (unknown origin) assessed as inhibition constant in presence of D-Ala-N-MePhe-Gly-ol-enkephalin and D-Ala-DLeu-enkephalin ChEBML_1447789 Inhibition of human recombinant PDGFRbeta using poly(Ala,Glu,Lys,Tyr) substrate ChEBML_1448579 Inhibition of human recombinant FLT3 using poly(Ala,Glu,Lys,Tyr) substrate ChEBML_1448594 Inhibition of human recombinant INSR using poly(Ala,Glu,Lys,Tyr) substrate ChEBML_1448595 Inhibition of human recombinant MET using poly(Ala,Glu,Lys,Tyr) substrate
AMINOLEVULINIC ACID BDBM50240386 CHEMBL601 Aminolevulinic Acid Hydrochloride Levulan delta-aminolevulinic acid 5-aminolevulinic acid 5-amino-4-oxopentanoic acid
Acetyl-Ala-Ala-Pro-Ala-trifluromethane BDBM50014742 CHEMBL130128
BDBM50250904 CHEMBL460657 elaidic acid trans-Delta(9)-octadecenoic acid Elaidinsaeure
CHEMBL384224 Tyr-c[Asp-Ala-Ala-Ala-Asn-Ala-Phe-Dpr]-Tyr-NH2 BDBM50144872
(2S)-2-{[(2S)-2-aminopropanoyl]amino}propanoic acid (S)-2-((S)-2-Amino-propionylamino)-propionic acid CHEMBL17697 Ala-Ala BDBM50016695
BDBM35258 Suc-Ala-Pro-Ala-MCA
Cbz-Ala-Ala-Asn-AMC BDBM22115
CHEMBL162547 BDBM50013368 Ala-Ala-Gly-Ala-Val-Val-Asn-Asp-Leu
CHEMBL164048 BDBM50013360 Tyr-Ala-Gly-Ala-Val-Ala-Asn-Asp-Leu
Delta(9)-octadecynoic acid CHEMBL482804 BDBM50292401 9-octadecynoic acid octadec-9-ynoic acid stearolic acid
CHEMBL456732 (9Z)-tetradec-9-enoic acid myristoleic acid BDBM50269530 cis-Delta(9)-tetradecenoic acid
5-carboxyfluorescein (5-FAM)-beta(Ala)-beta(Ala)-G-pY*LPQTV BDBM20245 beta(Ala)-beta(Ala)-G-pYLPQTV
alpha-linolenic acid (Z,Z,Z)-9,12,15-octadecatrienoic acid cis,cis,cis-9,12,15-octadecatrienoic acid cid_5280934 all-cis-9,12,15-octadecatrienoic acid 9-cis,12-cis,15-cis-octadecatrienoic acid (9,12,15)-linolenic acid CHEMBL8739 BDBM50240347 (9Z,12Z,15Z)-octadeca-9,12,15-trienoic acid linolenic acid ALA cis-Delta(9,12,15)-octadecatrienoic acid
(S)-alanine L-Alanin US11021454, Compound L-ala BDBM50000099 (S)-2-aminopropanoic acid Ala L-alpha-alanine CHEMBL279597 (2S)-2-aminopropanoic acid L-alanine
CHEMBL103140 H-Ala-Gly-Ala-Val-Val-Asn-Asp-Leu-OH Ala-Gly-Ala-Val-Val-Asn-Asp-Leu BDBM50013381
BDBM50014740 Acetyl-Pro-Ala-Pro-Ala-trifluoro methane CHEMBL130718
Ala-Val-Ala-Glu-lle-Gln-Leu-Met-His-Gln-Har-Ala-Lys-Trp BDBM50269971 CHEMBL514849
BDBM50269974 Ala-Val-Ala-Glu-lle-Gln-Leu-Nle-His-Gln-Har-Ala-Lys-Tyr CHEMBL450474
BDBM50033573 CHEMBL268322 Tyr-Ser-Phe-Lys-Asp-Ala-Pro-Leu-Ala-Arg Tyr-Ser-Phe-Lys-Asp-Ala-Pro-Leu-D-Ala-Arg
5-Aminopentanoic Acid 5-Ammoniopentanoate CHEMBL284116 DAVA Delta-Aminovalerianic Acid 5-Amino-Pentanoic Acid BDBM50026409 CHEBI:15887
Ala-Gly ((S)-2-Amino-propionylamino)-acetic acid (3-Amino-propionylamino)-acetic acid CHEMBL94250 BDBM50169210
CHEMBL426949 BDBM50015056 Ala-Thr-Ser-Asn-Val-Phe-Ala-OBzl
D-Ala-D-Ala BDBM50022571 D-alanyl-D-alanine CHEMBL299420
Suc-Ala-Ala-Pro-Phe-7-amino-4-methylcoumarin BDBM23729
Ala-Val-Ala-Glu-lle-Gln-Leu-Met-His-Gln-Har-Ala-Lys-Trp-Fly CHEMBL505612 BDBM50269972
Ala-Val-Ala-Glu-lle-Gln-Leu-Nle-His-Gln-Har-Ala-Lys-Trp-Tyr CHEMBL499651 BDBM50269973
BDBM82414 delta MSH
9-[N(delta)-propyl -delta-aminobutylamino]-1,2,3,4-tetrahydroacridine CHEMBL444150 BDBM50273429
BDBM50013375 Tyr-Ala-Gly-Ala-Val-Val-Asn-Asp-Phe CHEMBL163585
BDBM682271 DOTA[(Gd(III)]- Ala-D-Ala- boroPro US20240207292, Compound 6511Gd
CHEMBL2371367 BDBM50013384 Tyr-Ala-Gly-Ala-Val-Ile-Asn-Asp-Leu
CHEMBL349654 Tyr-Ala-Gly-Ala-Val-Val-Asn-Asp-Val BDBM50013380
CHEMBL349664 Leu-Ala-Gly-Ala-Val-Val-Asn-Asp-Leu BDBM50013350
CHEMBL351838 BDBM50013376 Tyr-Ala-Pro-Ala-Val-Val-Asn-Asp-Leu
CHEMBL430258 Arg-Ala-Thr-Ser-AsnVal-Phe-Ala-O-Benzyl BDBM50015068
CHEMBL434294 BDBM50013378 Phe-Ala-Gly-Ala-Val-Val-Asn-Asp-Leu
His-Ala-Gly-Ala-Val-Val-Asn-Asp-Leu BDBM50013373 CHEMBL350125
N-methylsuccinyl-Ala-Ala-Pro-Val-7-amino-4-methylcoumarin BDBM23699
Tyr-Pro-Ser-Lys-Pro-Asp-Asn-pro-[D-Ala]-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 BDBM50042810 CHEMBL437863 Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-D-Ala-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 Tyr-Pro-Ser-Lys-Pro-Asp-Asn-pro-[Ala]-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2
CHEMBL380047 BDBM50188504 Ala-Asp
CHEMBL541207 BDBM50407466 Leu-Ala
US8933056, Ala-boroAla BDBM142090
Ac-Tyr-Ala-Gly-Ala-Val-Val-Asn-Asp-Leu CHEMBL434474 BDBM50013371
BDBM50012298 CHEMBL438290 Ac-His-Trp-Ala-Val-Ala-His-Leu-Met-NH2
BDBM50013348 Tyr(oMe)-Ala-Gly-Ala-Val-Val-Asn-Asp-Leu CHEMBL162403
BDBM50013355 CHEMBL265148 Tyr-Ala-Gly-Ala-Val-Val-Asn-Asp-Leu-Lys
BDBM50013379 CHEMBL165071 Tyr-beta-Ala-Gly-Ala-Val-Val-Asn-Asp-Leu
BDBM609727 BDBM609732 US11707539, Compound 6511Gd DOTA[(Gd(III)]- Ala-D-Ala- boroPro
CHEMBL387234 BDBM50013351 Lys-Tyr-Ala-Gly-Ala-Val-Val-Asn-Asp-Leu
D-Tyr-Ala-Gly-Ala-Val-Val-Asn-Asp-Leu BDBM50013356 CHEMBL162068
Glu-Leu-Asp-Leu-(CHOH-CH2)-Ala-Ala-Glu-Phe CHEMBL363255 BDBM50155999
Tyr-Ala-Gly-Ala-Val-Val-Asn-Asp-Leu-NH2 CHEMBL165060 BDBM50013374
US20240207292, Compound 6511 DOTA-Ala-D- Ala-boroPro US11707539, Compound 6511 BDBM609724
desamino-Tyr-Ala-Gly-Ala-Val-Val-Asn-Asp-Leu BDBM50013345 CHEMBL423453
CHEMBL91241 Gly-Ala Gly-Arg (S)-2-(2-Amino-acetylamino)-propionic acid BDBM50188530
BDBM50311532 CHEMBL1076479 delta-Mercaptobutyricacid
Ac-His-Trp-Ala-Val-D-Ala-His-Leu-Met-NH2 CHEMBL263873 BDBM50012309
Ac-Tyr(OMe)-Ala-Gly-Ala-Val-Val-Asn-Asp-Leu BDBM50013362 CHEMBL162176
Ac-Tyr-D-Ala-Gly-Ala-Val-Val-Asn-Asp-Leu CHEMBL421853 BDBM50013352
BDBM50013347 CHEMBL387456 H2N-C8-Tyr-Ala-Gly-Ala-Val-Val-Asn-Asp-Leu
BDBM50013349 CHEMBL434089 Ac-Tyr-Ala-Gly-Ala-Val-Val-Asn-Asp-Leu-NH2
CHEMBL351856 BDBM50013369 Ac-D-Tyr-Ala-Gly-Ala-Val-Val-Asn-Asp-Leu
CHEMBL412249 Tyr-Ser-Phe-Lys-Asp-Met-Pro-Ala-D-Ala-Arg BDBM50033560
(S)-2-((S)-2-Amino-propionylamino)-3-hydroxy-propionic acid Ala-Ser CHEMBL190179 BDBM50169132
BDBM50085098 2-(2-Amino-propionylamino)-3-phenyl-propionic acid CHEMBL161461 DL-Ala-DL-Phe
BDBM223536 US9321743, Cbz-D-Ala
BDBM223538 US9321743, Cbz-L-Ala
BDBM50049719 CHEMBL1221478 Ile-Ala-Pro
BDBM50188495 CHEMBL210616 Phe-Ala-NH2
BDBM747624 US12325697, Compound ALA-5
CHEMBL214233 Tyr-Ala-hexarelin BDBM50125889
US8933056, Ala-boroAla Thioxamide BDBM142091
BDBM23922 Bz-beta-Ala-Gly-Arg-pNA benzoyl-beta-Ala-Gly-Arg-p-nitroanilide
BDBM50013357 CHEMBL412159 Ser-Thr-Ser-Tyr-Ala-Gly-Ala-Val-Val-Asn-Asp-Leu
BDBM82458 BIM 23049 D-Nal-Ala-Tyr-D-Trp-Lys-Val-Ala-Thr-NH2
CHEMBL525577 D-Phe-Gln-Trp-Ala-Val-b-Ala-His-Phe-Nle-NH2 BDBM50275902
human Neuropeptide Y Tyr-Pro-Ser-Lys-Pro-Asp-Asn-pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-[D-Ala]-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 Tyr-Pro-Ser-Lys-Pro-Asp-Asn-pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-[D-Tyr]-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 neuropeptide Y Tyr-Pro-Ser-Lys-Pro-Asp-Asn-pro-Gly-Glu-Asp-[D-Ala]-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 Tyr-Pro-Ser-Lys-Pro-Asp-Asn-pro-Gly-Glu-[D-Asp]-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 Tyr-Pro-Ser-Lys-Pro-Asp-Asn-pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-[D-Gln]-Arg-Tyr-NH2 Tyr-Pro-Ser-Lys-Pro-Asp-Asn-pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-[D-Ile]-Thr-Arg-Gln-Arg-Tyr-NH2 Tyr-Pro-Ser-Lys-Pro-Asp-Asn-pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-D-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 (NPY) BDBM50005530 Tyr-Pro-D-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 Tyr-Pro-Ser-Lys-Pro-Asp-Asn-pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-[D-Arg]-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-D-Arg-Tyr-NH2 Tyr-Pro-Ser-Lys-Pro-Asp-Asn-pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-[D-Ser]-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 Tyr-Pro-Ser-Lys-Pro-Asp-Asn-pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-[D-His]-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 Tyr-Pro-Ser-D-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 CHEMBL267633 NPY, porcine Tyr-Pro-Ser-Lys-Pro-Asp-Asn-pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-[D-Thr]-Arg-Gln-Arg-Tyr-NH2 Tyr-Pro-Ser-Lys-Pro-Asp-Asn-pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-[D-Arg]-Tyr-NH2 Tyr-Pro-Ser-Lys-Pro-Asp-Asn-pro-Gly-Glu-Asp-Ala-[D-Pro]-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 Tyr-Pro-Ser-Lys-Pro-Asp-Asn-pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-[D-Tyr]-NH2 Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2(NPY) NEUROPEPTIDE-Y Tyr-D-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 Tyr-Pro-Ser-Lys-Pro-Asp-Asn-pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-[D-Ala]-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 Tyr-Pro-Ser-Lys-Pro-Asp-Asn-pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-[D-Tyr]-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-D-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 D-Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 Tyr-Pro-Ser-Lys-Pro-Asp-Asn-pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-[D-Tyr]-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 [D-Tyr]-Pro-Ser-Lys-Pro-Asp-Asn-pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 Tyr-Pro-Ser-Lys-Pro-Asp-Asn-pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-[D-Leu]-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 Tyr-Pro-Ser-Lys-Pro-Asp-Asn-pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-[D-Arg]-Gln-Arg-Tyr-NH2 Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-D-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 Tyr-{D-Pro]-Ser-Lys-Pro-Asp-Asn-pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 Tyr-Pro-Ser-Lys-Pro-Asp-[D-Asn]-pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-D-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 Tyr-Pro-Ser-Lys-Pro-[D-Asp]-Asn-pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 Tyr-Pro-Ser-Lys-Pro-Asp-Asn-D-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 tyr-pro-ser-lys-pro-asp-asn-pro-gly-glu-asp-ala-glu-asp-leu-ala-arg-tyr-tyr-ser-ala-leu-arg-his-tyr-ile-asn-leu-ile-thr-arg-gln-arg-tyr-NH2 Tyr-Pro-Ser-Lys-Pro-Asp-Asn-[D-pro]-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 Nucleopeptide Y(NPY)(YPSKPDNPGEDAPAEDMARYYSALRHYINLITRQRY) Tyr-Pro-Ser-Lys-Pro-Asp-Asn-pro-Gly-Glu-Asp-Ala-Pro-[D-Ala]-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-D-Gln-Arg-Tyr-NH2 Tyr-Pro-Ser-Lys-Pro-Asp-Asn-pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-[D-Asp]-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 Tyr-Pro-Ser-Lys-Pro-Asp-Asn-pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-[D-Asn]-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 Tyr-Pro-Ser-[D-Lys]-Pro-Asp-Asn-pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 YPSKPDNPGEDAPAEDLARYYSALRHYINLITRQRY-NH2 Tyr-Pro-Ser-Lys-Pro-D-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 Tyr-Pro-Ser-Lys-Pro-Asp-Asn-pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-[D-Leu]-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 Tyr-Pro-Ser-Lys-Pro-Asp-Asn-pro-Gly-[D-Glu]-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-D-Arg-Gln-Arg-Tyr-NH2 Tyr-Pro-[D-Ser]-Lys-Pro-Asp-Asn-pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 Tyr-Pro-Ser-Lys-[D-Pro]-Asp-Asn-pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 Tyr-Pro-Ser-Lys-D-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 Tyr-Pro-Ser-Lys-Pro-Asp-Asn-pro-Gly-Glu-Asp-Ala-Pro-Ala-[D-Glu]-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-D-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 Tyr-Pro-Ser-Lys-Pro-Asp-Asn-pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-[D-Leu]-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-D-Tyr-NH2 Tyr-Pro-Ser-Lys-Pro-Asp-Asn-pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-[D-Ile]-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 H-YPSKPDNPGEDAPAEDMARYYSALRHYINLITRQRY-NH2
H-Tyr-Ala-Gly-Ala-Val-Val-Asn-Asp-Leu-OH 2-{2-[2-(2-{2-[2-(2-{2-[2-Amino-3-(4-hydroxy-phenyl)-propionylamino]-propionylamino}-acetylamino)-propionylamino]-3-methyl-butyrylamino}-3-methyl-butyrylamino)-3-carbamoyl-propionylamino]-3-carboxy-propionylamino}-4-methyl-pentanoic acid YAGA-VVNDL NH2-YAGAVVNDL-COOH BDBM50000140 Tyr-Ala-Gly-Ala-Val-Val-Asn-Asp-Leu Tyr-D-Ala-Gly-Ala-Val-Val-Asn-Asp-Leu CHEMBL430907
BDBM50139906 DPhe-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Nle-Ala-Arg-Ala-Glu-Gln-Leu-Ala-Gln-Glu-Ala-His-Lys-Asn-Arg-Lys-Leu-Nle-Glu-Ile-Ile-NH2 CHEMBL414991
Ac-Lys(N-epsilon-biotinoyl)-Ala-Ala-Bth-Thr(PO3H2)-Pro-ChaGln-NH2 BDBM50184833 CHEMBL440637
BDBM36236 Cbz-D-Ala-L-Trp
CHEMBL1222161 Met-Ala BDBM50485557 CHEBI:74394
CHEMBL430922 BDBM50284778 Z-Phe-Ala-H
Cbz-D-Ala-L-Phe BDBM36232
Cbz-D-Ala-L-Tyr BDBM36234
Cbz-L-Ala-L-Phe BDBM36233
Cbz-L-Ala-L-Trp BDBM36237
Cbz-L-Ala-L-Tyr BDBM36235
pTosyl-NeopentylAsn-Ala-LeuVSMe CHEMBL206001 BDBM50186696
Ac-Lys(N-epsilon-biotinoyl)-Ala-Ala-Nal-Thr(PO3H2)-Pro-tBuGly-Gln-NH2 CHEMBL267945 BDBM50184832
Ac-Lys(N-epsilon-biotinoyl)-Ala-Ala-Thi-Thr(PO3H2)-MeAla-Nal-Gln-NH2 BDBM50184840 CHEMBL405287
Ac-Lys(N-epsilon-biotinoyl)-Ala-Ala-tBuPhe-Thr(PO3H2)-Tic-Bth-Gln-NH2 BDBM50184828 CHEMBL414584
Ac-Lys(N-epsoilon-biotinoyl)-Ala-Ala-Thi-Thr(PO3H2)-Pro-Bip-Gln-NH2 CHEMBL268078 BDBM50184827
BDBM50139910 CHEMBL438724 Ac-(Glu-Ala-His-Lys)-Leu-Ala-Lys-Leu-Nle-Glu-Ile-Ile-NH2
BDBM50184823 CHEMBL438271 Ac-Lys(N-epsilon-biotinoyl)-Ala-Ala-Bip-Thr(PO3H2)-Pro-Nal-Gln-NH2
BDBM50184824 CHEMBL219287 Ac-Lys(N-epsilon-biotinoyl)-Ala-Ala-Phe-Thr(PO3H2)-MeAla-Bth-Gln-NH2
BDBM50184826 Ac-Lys(N-epsilon-biotinoyl)-Ala-Ala-tBuPhe-Thr(PO3H2)-MeAla-Nal-Gln-NH2 CHEMBL411584
BDBM50184831 Ac-Lys(N-epsilon-biotinoyl)-Ala-Ala-Cha-Thr(PO3H2)-Tic-Nal-Gln-NH2 CHEMBL437349
BDBM50184835 Ac-Lys(N-epsilon-biotinoyl)-Ala-Ala-Bth-Thr(PO3H2)-Pro-Nal-Gln-NH2 CHEMBL413855
BDBM50184837 CHEMBL558539 Ac-Lys(N-epsilon-biotinoyl)-Ala-Ala-tBuPhe-Thr(PO3H2)-Pro-Nal-Gln-NH2
BDBM50287881 Suc-Glu-Ala-Val-Tyr-Phe-Ala-His-Leu-Asp-lle-lle-Gly-COOH CHEMBL216772
BDBM50287882 CHEMBL412065 Suc-Glu-Ala-Val-Tyr-Phe-Ala-Gly-Leu-Asp-lle-lle-Trp-COOH
BDBM50287883 Suc-Glu-Ala-Gly-Tyr-Phe-Ala-His-Leu-Asp-lle-lle-Trp-COOH CHEMBL412003
BDBM50287884 CHEMBL411399 Suc-Glu-Ala-Val-Tyr-Phe-Ala-His-Leu-Asp-Gly-lle-Trp-COOH
CHEMBL218960 BDBM50184839 Ac-Lys(N-epsilon-biotinoyl)-Ala-Ala-Nal-Thr(PO3H2)-Pro-Cha-Gln-NH2
CHEMBL219523 Ac-Lys(N-epsilon-biotinoyl)-Ala-Ala-Cha-Thr(PO3H2)-MeAla-Nal-Gln-NH2 BDBM50184829
CHEMBL405377 Suc-Glu-Ala-Val-Tyr-Phe-Ala-His-Leu-Gly-lle-lle-Trp-COOH BDBM50287885
CHEMBL405753 Suc-Glu-Ala-Val-Tyr-Phe-Ala-His-Leu-Asp-lIe-Gly-Trp-COOH BDBM50287879
CHEMBL405796 Suc-Glu-Ala-Val-Tyr-Phe-Ala-His-Gly-Asp-lle-lle-Trp-COOH BDBM50287886
CHEMBL413604 BDBM50287887 Suc-Glu-Ala-Val-Gly-Phe-Ala-His-Leu-Asp-lle-lle-Trp-COOH
CHEMBL425273 BDBM50184836 Ac-Lys(N-epsilon-biotinoyl)-Ala-Ala-Bip-Thr(PO3H2)-Pro-Bth-Gln-NH2
CHEMBL441398 BDBM50184830 Ac-Lys(N-epsilon-biotinoyl)-Ala-Ala-Bth-Thr(PO3H2)-Pip-Nal-Gln-NH2
Suc-Glu-Ala-Val-Tyr-Gly-Ala-His-Leu-Asp-lle-lle-Trp-COOH CHEMBL412002 BDBM50287889
Suc-Glu-Ala-Val-Tyr-Phe-Ala-His-Leu-Asp-lle-lle-Trp-COOH CHEMBL427778 BDBM50287890
Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-OH BDBM50034128 Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr CHEMBL441396 Neuropeptide Y(NPY)
(S)-2-((S)-2-Amino-propionylamino)-3-(4-hydroxy-phenyl)-propionic acid CHEMBL94016 Ala-Tyr BDBM50188523
BDBM50169129 Tyr-Ala CHEMBL316103 (S)-2-[(S)-2-Amino-3-(4-hydroxy-phenyl)-propionylamino]-propionic acid
BDBM84909 THC, 11-OH-delta 9
BDBM84918 THC, 11-OH-delta 8
THC, 2-I-delta 8 BDBM84887
palmitolinoleic acid palmitoleic acid 16:1Delta9 cis-Delta(9)-hexadecenoic acid CHEMBL453509 BDBM50269531 Palmitoleic acid (PoA) zoomaric acid (Z)-hexadec-9-enoic acid 9-cis-hexadecenoic acid (9Z)-hexadec-9-enoic acid (Z)-9-hexadecenoic acid
BDBM50013364 CHEMBL2371380 Glu-Cys-Arg-Ser-Thr-Ser-Tyr-Ala-Gly-Ala-Val-Val-Asn-Asp-Leu
BDBM50184825 CHEMBL219531 Ac-Lys(N-epsilon-biotinoyl)-Ala-Ala-Bth-D-Thr(PO3H2)-Pip-Nal-Gln-NH2
Lys-Ala-p-nitroaniline BDBM12196 Lys-Ala-pNA 2,6-diamino-N-{1-[(4-nitrophenyl)carbamoyl]ethyl}hexanamide
CHEMBL429531 Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Leu-Thr-Arg-Pro-Arg-Tyr BDBM50099198
CHEMBL191057 Ala-Lys BDBM50169125 6-Amino-2-(2-amino-propionylamino)-hexanoic acid (S)-6-Amino-2-((S)-2-amino-propionylamino)-hexanoic acid
(S)-2-((S)-2-Amino-propionylamino)-3-(1H-indol-3-yl)-propionic acid CHEMBL91792 Ala-Trp BDBM50188485
BDBM50186689 CHEMBL383529 Ac-Glu(OtBu)-Ala-LeuVSMe
BDBM50186694 CHEMBL207336 benzoyl-Glu(OtBu)-Ala-LeuVSMe
BDBM50186716 Ac-hPhe-Leu-Ala-LeuVSMe CHEMBL207579
BDBM50186717 Cbz-Ile-hPhe-Ala-LeuVSMe CHEMBL446443
BDBM50186718 CHEMBL207394 Ac-Glu(OBn)-Ala-LeuVSMe
BDBM50186724 Cbz-Ile-CyclohexylGlu-Ala-LeuVSMe CHEMBL207669
BDBM50300363 CHEMBL583426 Tyr-D-Ala-Gly-NMePhe
BDBM50301668 CHEMBL577749 Tyr-Pro-Phe-Ala-Bn
BDBM86418 Dmt-d-Ala-Phe-Phe-NH2
CHEMBL207284 BDBM50186688 Cbz-Ile-Phe-Ala-LeuVSMe
CHEMBL382203 Cbz-Ile-NeopentylAsn-Ala-LeuVSMe BDBM50186721
CHEMBL383730 BDBM50186704 Cbz-Ile-MetO2-Ala-LeuVSMe
CHEMBL437882 BDBM50186692 Cbz-Ile-hGln-Ala-LeuVSMe
Cbz-Glu(OtBu)-Ala-LeuVSMe CHEMBL208015 BDBM50186685
Cbz-Ile-Gln-Ala-LeuVSMe BDBM50186700 CHEMBL382180
Cbz-Ile-Leu-Ala-LeuVSMe BDBM50186687 CHEMBL207403
Cbz-Ile-NeopentylGln-Ala-LeuVSMe CHEMBL378901 BDBM50186708
Cbz-Ile-Pro-Ala-LeuVSMe CHEMBL207670 BDBM50186703
Cbz-Ile-iPrGln-Ala-LeuVSMe BDBM50186711 CHEMBL437115
pTosyl-Glu(OtBu)-Ala-LeuVSMe BDBM50186710 CHEMBL207016
t-Boc-Gln-Ala-Arg-AMC BDBM21738
BDBM85748 Nphe H-PHE-(R)-GLY-GLY-PHE-THR-GLY-ALA-ARG-LYS-SER-ALA-ARG-LYS-NH2
CHEMBL409888 BDBM50013354 H-Gly-Ala-Val-Val-Asn-Asp-Leu-OH Gly-Ala-Val-Val-Asn-Asp-Leu
BDBM50042811 Tyr-Pro-Ser-Lys-Pro-Asp-Asn-pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-[D-Arg]-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 CHEMBL127282
(6,9,12)-linolenic acid gamolenic acid (Z,Z,Z)-6,9,12-octadecatrienoic acid all-cis-6,9,12-octadecatrienoic acid (6Z,9Z,12Z)-octadeca-6,9,12-trienoic acid BDBM50269532 US9061023, gamma-Linolenic acid cis-Delta(6,9,12)-octadecatrienoic acid CHEMBL464982 gamma-linolenic acid
BDBM84911 THC, 1-O-biphenylmethyl-delta 9,11
THC, 1-O-Methyl-delta 8 BDBM84891
THC, 1-O-biphenylmethyl-delta 8 BDBM84890
THC, 1-O-methyl-delta 9,11 BDBM84893
delta-valerolactam BDBM10 CHEMBL12193 piperidin-2-one
CHEMBL3559527 BDBM50003049 Tyr-Pro-Ser-Lys-Pro-Ala-Asn-Pro-Gly-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr
CHEMBL438915 AcMet-Ile-Lys-Ala-Phe-Thr-Glu-Met-Met-Val-Val-Ala-Ser-Gln-Leu-Alr-Ala-Asn-Ile-Ser-His-Lys-Asp-Met-Gln-Leu-Gly-Arg BDBM50012294
Tyr-Ala-D-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg(D-Asp3,(1-29)-NH2) Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg(D-Ala2(1-29)-NH2) BDBM50004966 Tyr-Ala-Asp-Ala-Ile-Phe-Thr-D-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg(D-Asn8,(1-29)-NH2) Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg(GRF(1-29)-NH2) CHEMBL428135 Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2
CHEMBL278549 Met-Phe-Leu-Glu-Ala-Ile-Pro-Met BDBM50089096 ent-Met-Phe-Leu-Glu-Ala-Ile-Pro-Met
BDBM50034125 Neuropeptide Y(NPY)(13-36) Pro-Ala-Glu-Asp-Leu-Ala-Arg-tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr CHEMBL265849
Ac-hPhe-Leu-(D)-Ala-LeuVSMe BDBM50186701 CHEMBL438442
BDBM50175966 CHEMBL199376 Bz-Nle-Lys-Arg-Ala-H
BDBM50175976 CHEMBL197765 Bz-Ala-Lys-Arg-Arg-H
BDBM50186690 Cbz-Ile-trans-StyrylAla-Ala-LeuVSMe CHEMBL208159
BDBM50186706 CHEMBL438612 Cbz-Ile-t-ButylGln-Ala-LeuVSMe
BDBM50301665 CHEMBL577747 Tyr-Pro-Trp-D-Ala-Bn
BDBM50301666 CHEMBL577748 Tyr-Pro-Phe-D-Ala-Bn
Bz-Nle-Ala-Arg-Arg-H BDBM50175970 CHEMBL369916
CHEMBL207162 BDBM50186709 Cbz-Ile-Glu(OtBu)-Ala-LeuVSMe
CHEMBL207196 BDBM50186698 Cbz-Ile-t-ButylhomoGlu-Ala-LeuVSMe
CHEMBL372963 Bz-Nle-Lys-Ala-Arg-H BDBM50175983
CHEMBL379771 BDBM50186705 Cbz-Ile-Asp-(OtBu)-Ala-LeuVSMe
CHEMBL379772 Cbz-Ile-Ser(OBn)-Ala-LeuVSMe BDBM50186693
CHEMBL439332 BDBM50190379 bip-tyr-thr-ala-pro-phe
CHEMBL509495 N-dansyl-Tyr-Val-D-Ala BDBM50273316
CHEMBL589082 BDBM50308382 H-Ala-Pro-Phe-Phe-NH2
Cbz-Ile-Asp(OBn)-Ala-LeuVSMe BDBM50186726 CHEMBL204518
Ser-Asn-Val-Cha-Ala-OBzl CHEMBL173179 BDBM50015058
US9434690, BOC-GLU(OBZL)-ALA-ARG-AMC BDBM246300
BDBM50091749 Cyclic-(Cys-Phe-Gly-Gly-Arg-Ala-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys) CHEMBL412793
Cyclic-(Cys-Phe-Gly-Gly-Ala-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys) CHEMBL264744 BDBM50091757
Cyclic-(Cys-Phe-Gly-Gly-Arg-Ile-Ala-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys) BDBM50091750 CHEMBL415133
BDBM50003056 c(7,20)-Tyr-Pro-Ser-Lys-Pro-Asp-Glu-Pro-Ala-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr CHEMBL415353
BDBM50004979 CHEMBL440262 Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-OH
BDBM50004989 CHEMBL265167 His-Ala-Asp-Ala-Ile-Phe-Thr-Ser-Ser-Tyr-Arg-Arg-Ile-Leu-Gly-Gln-Leu-Tyr-Ala-Arg-Lys-Leu-Leu-His-Glu-Ile-Met-Asn-Arg-NH2
8-Hydroxy-7,9-dimethyl-delta-carboline BDBM50251146 CHEMBL458465
BDBM50251147 CHEMBL458947 8-Hydroxy-5,7,9-trimethyl-delta-carboline
BDBM84881 THC, 9-Nor-9-carboxy-delta 8
THC, 9-Nor-9-carboxy-delta 9 BDBM84885
delta 19,20-bryostatin 10 bryostatin 17 CHEMBL452391 BDBM50292350
BDBM50108534 CHEMBL427580 NH2-Thr-Asn-Ile-Lys-Thr-Glu-Glu-Ile-Ser-Glu-Val-Asn-Leu-Ala-Ala-Glu-Phe-Arg
CHEMBL2371374 BDBM50013353 Thr-Asp-Phe-Phe-Glu-Cys-Arg-Ser-Thr-Ser-Tyr-Ala-Gly-Ala-Val-Val-Asn-Asp-Leu
CHEMBL413728 BDBM50108530 NH2-Thr-Asn-Ile-Lys-Thr-Glu-Glu-Ile-Ser-Glu-Val-Asn-Ala-Asp-Ala-Glu-Phe-Arg
haTRAP BDBM85087 L-Ala-4-Fluoro-L-Phe-L-Arg-3-cyclohexyl-L-Ala-N-amidino-L-Lys-L-Phe-NH2
CHEMBL2369457 [Val-Thr-His-Ala-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2] hCG BDBM50000746
CHEMBL2369458 [Val-Thr-His-Arg-Ala-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2] hC BDBM50000749
CHEMBL2369459 BDBM50000750 [Val-Ala-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2] hC
[Val-Thr-Ala-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2] hC BDBM50000744 CHEMBL2369464
Ac-Phe-[Orn-Ala-cha-Trp-Arg] CHEMBL405646 BDBM50192061
Ac-Phe-[Orn-Pro-ala-Trp-Arg] CHEMBL407285 BDBM50192067
Ala-Asp-Lys(epsilon-thioAc)Thr-Ile CHEMBL523676 BDBM50257347
BDBM21631 Dansyl-Gly-(p-NO2)Phe-beta-Ala DGPA
BDBM50013365 CHEMBL162919 Tyr-Ala-Val-Val-Asn-Asp-Leu
BDBM50022516 Boc-Trp-Trp-Sta-Ala-Sta-OMe CHEMBL3142766
BDBM50122068 Ac-His-D-Phe-Arg-Ala-NH2 CHEMBL359318
BDBM50192048 Ac-Ala-[Orn-Pro-cha-Trp-Arg] CHEMBL267491
BDBM50192059 CHEMBL214024 Ac-Ala-[Orn-Pro-cha-Trp-Eag]
BDBM50207834 H-Apa-ala-Gly-Phe-leu-OH CHEMBL247363
BDBM50207837 CHEMBL247163 H-Cxp-ala-Gly-Phe-leu-OH
BDBM50257408 His-Lys-Lys(epsilon-thioAc)Leu-Ala CHEMBL449883
CHEMBL214456 BDBM50192039 Ac-Phe-[Orn-Pro-cha-Trp-Ala]
CHEMBL246572 H-Aba-ala-Gly-Phe-Met-OH BDBM50207833
CHEMBL246682 BDBM50207829 H-mCpa-ala-Gly-Phe-leu-OH
CHEMBL247064 H-Aba-ala-Gly-Phe-leu-OH BDBM50207821
CHEMBL247562 BDBM50207838 H-Poa-ala-Gly-Phe-leu-OH
CHEMBL262310 BDBM50133049 Opioid Peptide [d-Ala(8)]Dynorphin derivative
CHEMBL275924 BDBM50064852 Y-Pen-Y-D-Ala-SFCKK-NH2
CHEMBL3349390 Boc-Phe-Phe-Sta-Ala-Sta-OMe BDBM50022509
CHEMBL3349392 BDBM50022511 Boc-Trp-His-Sta-Ala-Sta-OMe
CHEMBL367267 Ser-Asn-Val-Phe-Ala-NH-Bzl BDBM50015064
CHEMBL385012 Ac-Phe-[Orn-Pro-cha-Ala-Arg] BDBM50192055
CHEMBL405057 Opioid Peptide [d-Ala(8)]Dynorphin derivative BDBM50133053
CHEMBL412228 Opioid Peptide [d-Ala(8)]Dynorphin derivative BDBM50133054
CHEMBL429351 BDBM50133048 Opioid Peptide [d-Ala(8)]Dynorphin derivative
CHEMBL453807 BDBM50257406 His-Ala-Lys(epsilon-thioAc)Leu-Met
CHEMBL492521 Ser-Asp-Lys(epsilon-thioAc)Thr-Ala BDBM50257404
CHEMBL504711 Ala-Lys-Lys(epsilon-thioAc)Leu-Met BDBM50257405
H-Cdp-ala-Gly-Phe-leu-OH BDBM50207832 CHEMBL247758
His-Lys-Lys(epsilon-thioAc)Ala-Met CHEMBL504310 BDBM50257407
Met-ψ[P(O)(OH)CH2]-Ala (5) BDBM234297
Opioid Peptide [d-Ala(8)]Dynorphin derivative BDBM50133055 CHEMBL441198
Opioid Peptide [d-Ala(8)]Dynorphin derivative BDBM50133056 CHEMBL262838
Opioid Peptide [d-Ala(8)]Dynorphin derivative CHEMBL385696 BDBM50133050
Opioid Peptide [d-Ala(8)]Dynorphin derivative CHEMBL413832 BDBM50133051
Opioid Peptide [d-Ala(8)]Dynorphin derivative CHEMBL430081 BDBM50133052
Ser-Ala-Lys(epsilon-thioAc)Thr-Ile CHEMBL492925 BDBM50257348
Ser-Asn-Val-(CH2-NH)-Phe-Ala CHEMBL176691 BDBM50015038
Ser-Asp-Lys(epsilon-thioAc)Ala-Ile CHEMBL523498 BDBM50257349
Thr-Ser-Asn-Val-Phe-Ala-OBzl CHEMBL173685 BDBM50015047
bip-tyr-thr-ala-thr(obzl)-gly CHEMBL209752 BDBM50190381
CHEMBL414570 AcMet-Val-Val-Ala-Ser-Gln-Leu-Arg-Ala-Asn-Ile-Ser-His-Lys-Asp-Met-Gln-Leu-Gly-Arg BDBM50012292
H-Ala-Pro-p-nitroaniline H-Ala-Pro-pNA BDBM11114 (2S)-1-[(2S)-2-aminopropanoyl]-N-(4-nitrophenyl)pyrrolidine-2-carboxamide hydrochloride
Mca-Ala-Pro-Lys(Dnp)-OH Mca-APK(Dnp)OH (7-methoxycoumarin-4-yl)acetyl-Ala-Pro-Lys(2,4-dinitrophenyl)-OH BDBM21453
Tyr-Gly-Gly-Phe-Leu-Arg-Arg-D-Ala-Arg-Pro-Lys-NH2 Opioid Peptide [d-Ala(8)]Dynorphin derivative BDBM50079413 CHEMBL407084
CHEMBL263451 BDBM50087709 lactum astressin(cyclo(30-33)-[D-Phe12,Nle21,38,Glu30,Lys33]r/h-CRF12-41 orD-Phe-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Nle-Ala-Arg-Ala-Glu-Gln-Leu-Ala-Gln-cyclo(-Glu-Ala-His-Lys)-Asn-Arg-Lys-Leu-Nle-Glu-Ile-Ile-NH2)
CHEMBL57338 2-(2-Amino-propionylamino)-3-phenyl-propionic acid anion BDBM50188503 Ala-Phe 2-(2-Amino-propionylamino)-3-phenyl-propionic acid (S)-2-((S)-2-Amino-propionylamino)-3-phenyl-propionic acid
[D-Ala-3] Dynorphin A (1-11)-NH2H-Tyr-Gly-D-Ala-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-NH2 Tyr-Gly-[D-Ala]-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-NH2 CHEMBL405190 BDBM50090003
BDBM50003047 c(30,34)-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Dpr-Ile-Thr-Arg-Glu-Arg-Tyr CHEMBL438211
BDBM50085754 cyclo(1,1'-3)Ac-D-Asp (Ala)-D-Cpa-D-Orn-Ser-Tyr-D-Arg-Leu-Arg-Pro-D-Ala-NH2 CHEMBL402697
BDBM50085767 cyclo(1,1'-3)Ac-D-Asp (Ala)-D-Cpa-D-Dbu-Ser-Tyr-D-Nal-Leu-Arg-Pro-D-Ala-NH2 CHEMBL262106
CHEMBL406025 c(30,34)-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Lys-Ile-Thr-Arg-Glu-Arg-Tyr BDBM50003054
CHEMBL410999 cyclo(1,1'-3)Ac-D-Asp (Ala)-D-Cpa-D-Orn-Ser-Tyr-D-Nal-Leu-Arg-Pro-D-Ala-NH2 BDBM50085749
CHEMBL425080 BDBM50003045 c(30,34)-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-orn-Ile-Thr-Arg-Glu-Arg-Tyr
c(33,36)-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Lys-Ile-Thr-Lys-Gln-Arg-glu CHEMBL413658 BDBM50003052
Cyclo (5,5'-8) [Ac-D Nal, Cpa, D Pal, Asp, Glu(beta Ala), D Arg, Leu, (D or L) AgI, Pro, D Ala]GnRH BDBM50085713 Cyclo (5,5'-8) [Ac-D Nal, Cpa, D Pal, Asp, Glu(beta Ala), D Arg, Leu, (L or D) AgI, Pro, D Ala]GnRH CHEMBL262160
BDBM50050525 CHEMBL63860 (R)-1-((S)-2-aminopropanoyl)pyrrolidin-2-ylboronic acid US11559537, Compound 1129 US8933056, Ala-boroPro US11096924, DASH-inhibitors 1129 Boronic acid derivative US8933056, Asp-boroPro
Tyr-Pro-Ser-Lys-Pro-Lys-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu5-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser BDBM50003053 CHEMBL265637
Ac-D-Phe-Leu-Asp-Ile-Ala-Trp BDBM50045225 CHEMBL86737
BDBM234298 Nle-ψ[P(O)(OH)O]-L-Ala (6)
BDBM50013367 CHEMBL162321 Tyr-Gly-Ala-Val-Val-Asn-Asp-Leu
BDBM50022512 CHEMBL3349394 Ibu-His-Pro-Phe-Ala-Sta-Leu-PheNH2
BDBM50022862 Boc-Phe-Ala-Leu-Val-Ile-His-OMe CHEMBL101874
BDBM50060795 [D or LAgl (Me, isopropyl--Ala)8]acyline CHEMBL2370590
BDBM50136347 Glu-Val-Met-statine-Val-Ala-Glu-Phe CHEMBL335837
BDBM50190376 CHEMBL383931 bip-ala-thr-pro-lys-thr(obzl)-gly
BDBM50190385 CHEMBL219358 bip-tyr-thr-pro-ala-thr(obzl)-gly
BDBM50190389 CHEMBL277108 bip-tyr-ala-pro-lys-thr(obzl)-gly
BDBM50265074 Cbz-Phe-[Gly-cis epoxy-Gly]-Ala-AlaOMe CHEMBL525792
BDBM50342261 CHEMBL1766926 H-Arg-Arg-Pro-Ala-Ile-Leu-OH
CHEMBL134730 Glu-Val-Met-statine-Leu-Ala-Glu-Phe BDBM50136342
CHEMBL137755 BDBM50136343 Glu-Val-Asn-statine-Val-Ala-Glu-Phe
CHEMBL1766923 H-Ala-Arg-Pro-Tyr-Ile-Leu-OH BDBM50342246
CHEMBL1766925 H-Arg-Arg-Ala-Tyr-Ile-Leu-OH BDBM50342256
CHEMBL21028 BDBM50089097 Met-Phe-Leu-Glu-Ala-Ile-Pro-Lys
CHEMBL219062 BDBM50190378 bip-tyr-thr-ala-lys-thr(obzl)-gly
CHEMBL406279 BDBM50045262 Ac-D-Phe-Ala-Asp-Ile-Ile-Trp
CHEMBL411144 BDBM50060782 [L or DAgl (Me, isopropyl--Ala)8]acyline
CHEMBL500638 BDBM50265073 Cbz-Phe-[Gly-trans epoxy-Gly]-Ala-AlaOMe
CHEMBL87243 Ac-D-Phe-Leu-Asp-Ala-Ile-Trp BDBM50045237
H-Arg-Ala-Pro-Tyr-Ile-Leu-OH BDBM50342252 CHEMBL1766924
H-Arg-Arg-Pro-Tyr-Ile-Ala-OH CHEMBL1766927 BDBM50342268
L-363,376 cyclo(Pro-Ala-Trp-Lys-Thr-Phe) BDBM84645
MCL-451 CHEMBL384915 H-Dmt-Tic-beta-Ala-OH BDBM50194275
(7-methoxycoumarin-4-yl)acetyl-Ala-Ser-Asp-Lys(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-OH BDBM21476 Mca-Ala-Ser-Asp-Lys-Dpa-OH
BDBM50085742 CHEMBL414350 cyclo(1,1'-3)Ac-D-Asp (beta-Ala)-D-Cpa-D-Orn-Ser-Tyr-D-Nal-Leu-Arg-Pro-D-Ala-NH2
BDBM50085743 CHEMBL404991 cyclo(1,1'-3)Ac-D-Orn (beta-Ala)-D-Cpa-D-Asp-Ser-Tyr-D-Nal-Leu-Arg-Pro-D-Ala-NH2
BDBM50085755 cyclo(1,1'-3)Ac-D-Asp (D-Ala)-D-Cpa-D-Orn-Ser-Tyr-D-Nal-Leu-Arg-Pro-D-Ala-NH2 CHEMBL405781
CHEMBL407082 cyclo(1,1'-3)Ac-D-Glu (beta-Ala)-D-Cpa-D-Lys-Ser-Tyr-D-Nal-Leu-Arg-Pro-D-Ala-NH2 BDBM50085741
cyclo(1,1'-3)Ac-D-Asp (beta-Ala)-D-Cpa-D-Dbu-Ser-Tyr-D-Nal-Leu-Arg-Pro-D-Ala-NH2 BDBM50085757 CHEMBL427745
cyclo(1,1'-3)Ac-D-Asp (beta-Ala)-D-Cpa-D-Dpr-Ser-Tyr-D-Nal-Leu-Arg-Pro-D-Ala-NH2 CHEMBL437230 BDBM50085751
cyclo(1-3)Ac-D-Asp (D-Ala)-D-Cpa-D-Dbu-Ser-Tyr-D-Nal-Leu-Arg-Pro-D-Ala-NH2 CHEMBL264291 BDBM50085763
BDBM50015490 human Neuropeptide Y CHEMBL438945 NPY Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro- Ala-Glu-Asp-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His- Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 (NPY) NPY, human H-YPSKPDNPGEDAPAEDMARYYSALRHYINLITRQRY-NH2 NPY, human, rat
BDBM84889 THC-DMH, (+)-11-OH THC, 11-OH-delta 8
2-{2-[2-(2-{4-[2-(2-Acetylamino-3-methyl-butyrylamino)-4-methylsulfanyl-butyrylamino]-3-hydroxy-6-methyl-heptanoylamino}-3-methyl-butyrylamino)-propionylamino]-propionylamino}-3-phenyl-propionic acid(Ac-Val-Met-Sta-Val-Ala-Ala-Phe-COOH) CHEMBL2370097 BDBM50108539
BDBM50108522 CHEMBL2370115 4-[2-(2-{4-[2-(2-Acetylamino-3-methyl-butyrylamino)-4-methylsulfanyl-butyrylamino]-3-hydroxy-6-methyl-heptanoylamino}-3-methyl-butyrylamino)-propionylamino]-4-(1-carboxy-ethylcarbamoyl)-butyric acid(Ac-Val-Met-Sta-Val-Ala-Glu-Ala-COOH)
BDBM50108545 CHEMBL2370096 4-[2-(2-{4-[2-(2-Acetylamino-3-methyl-butyrylamino)-4-methylsulfanyl-butyrylamino]-3-hydroxy-6-methyl-heptanoylamino}-3-carboxy-propionylamino)-propionylamino]-4-(1-carboxy-ethylcarbamoyl)-butyric acid(Ac-Val-Met-Sta-Asp-Ala-Glu-Ala-COOH)
BDBM50108557 4-[2-(2-{4-[2-(2-Acetylamino-3-methyl-butyrylamino)-4-methylsulfanyl-butyrylamino]-3-hydroxy-6-methyl-heptanoylamino}-propionylamino)-propionylamino]-4-(1-carboxy-2-phenyl-ethylcarbamoyl)-butyric acid(Ac-Val-Met-Sta-Ala-Ala-Glu-Phe-COOH) CHEMBL90615
CHEMBL2370107 BDBM50108521 4-[2-(2-{4-[2-(2-Acetylamino-3-methyl-butyrylamino)-4-methylsulfanyl-butyrylamino]-3-hydroxy-6-methyl-heptanoylamino}-3,3-dimethyl-butyrylamino)-propionylamino]-4-(1-carboxy-ethylcarbamoyl)-butyric acid(Ac-Val-Met-Sta-tleu-Ala-Glu-Ala-COOH)
BDBM50139892 (S)-2-((S)-2-Amino-3-phenyl-propionylamino)-propionic acid Phe-Ala (S,S)2-(2-phenyl-1-trimethylammonioethylcarboxamido)propanoate CHEMBL429950
Ac-Tyr-Ala-Gly-Val-Val-Asn-Asp-Leu BDBM50013346 CHEMBL264705
Ac-Tyr-Gly-Ala-Val-Val-Asn-Asp-Leu CHEMBL436439 BDBM50013361
BDBM233005 H-D-Ser-Ala-Arg-NH-(CH2)5-NH2 (4)
BDBM233006 H-D-Ser-Ala-Arg-NH-(CH2)6-NH2 (5)
BDBM233007 H-D-Ser-Ala-Arg-NH-(CH2)7-NH2 (6)
BDBM233008 H-D-Ser-Ala-Arg-NH-(CH2)8-NH2 (7)
BDBM233009 H-D-Ser-Ala-Arg-NH-(CH2)9-NH2 (8)
BDBM233011 H-D-Ser-Ala-Arg-NH-(CH2)3-OH (10)
BDBM50015082 Ser-Asn-CH=CH-Val-Phe-Ala-NH-Bzl CHEMBL367080
BDBM50089094 Met-Phe-Leu-Glu-Ala-Ile-Pro-Met-Ser CHEMBL414810
BDBM50121916 His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 CHEMBL433540
BDBM50222728 cyclo(-L-Am7(S2Py)-A2in-L-Ala-D-Pro-) CHEMBL394261
BDBM50222737 CHEMBL238587 cyclo(-L-Am7(S2Py)-Aib-L-Ala-D-Tic-)
BDBM682273 DOTA[(Gd(III)]- HyBz-D-Ala- boroPro US20240207292, Compound 5183
CHEMBL2371369 BDBM50013377 desamino-Tyr-Ala-Gly-Thr-Ile-Asn-Asp-Leu
CHEMBL318242 BDBM50022864 Boc-Phe-(CH3)Ala-Leu-Val-Ile-His-OMe
CHEMBL351165 Tyr-Ala-Gly-Pro-Val-Val-Asn-Asp-Leu BDBM50013363
CHEMBL362838 Tyr-Ser-Thr-cyclo(Cys-Ala-Phe-Ile-Met) BDBM50151874
CHEMBL412705 BDBM50064849 Y-c[-Pen-Y-D-Ala-SFC]KK-NH2
CHEMBL499595 BDBM50268531 c[L-Ala-D-pro-L-Phe-D-trp]
DOTA[(Cu(II)]- Ser-D-Ala- boroPro BDBM609657 US11707539, Compound 6509CU
DOTA[(Cu(II)]- Ser-D-Ala- boroPro US20240207292, Compound 6509CU BDBM682258
DOTA[Gd(III)]- HyNic-D-Ala- boroPro BDBM682272 US20240207292, Compound 5180
H-D-Ser-Ala-Arg-NH-(CH2)2-OH (9) BDBM233010
H-D-Ser-Ala-Arg-NH-(CH2)4-OH (11) BDBM233012
H2N-Phe-Gly-His-Nph-Phe-Ala-Phe-OMe BDBM50022523 CHEMBL347185
Ser-Asn-Val-CH=CH-Phe-Ala-O-Bzl CHEMBL366854 BDBM50015062
Tyr-Ala-Gly-Thr-Val-Val-Asn-Asp-Leu CHEMBL2371362 BDBM50013370
US11707539, Compound 5183 BDBM609729 DOTA[(Gd(III)]- HyBz-D-Ala- boroPro
US20240207292, Compound 6489Gd BDBM682270 DOTA[Gd]- GABA-HyBz-D- Ala-boroPro
Phe-Thr-Glu-Met-Met-Val-Val-Ala-Ser-Gln-Leu-Alr-Ala-Asn-Ile-Ser-His-Lys-Asp-Met-Gln-Leu-Gly-Arg CHEMBL429238 BDBM50012291
(S)-2-[(S)-2-Amino-3-(1H-indol-3-yl)-propionylamino]-propionic acid (S)-2-((S)-2-amino-3-(1H-indol-3-yl)propanamido)propanoic acid BDBM50169160 Trp-Ala CHEMBL188866
Pro-Phe-His-delta-ornithine-Val-Tyr-Lys-NH2 BDBM50022973 CHEMBL2371819
THC, delta 9 US9416103, Δ9-THC CAS_1972-08-3 BDBM86515 NSC_16078
BDBM50004974 CHEMBL413014 Ac-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg(Ac-Tyr1,(1-29)-NH2) Ac-hGRF(1-29)NH2
(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-eicosapentaenoic acid (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoic acid 5,8,11,14,17-EICOSAPENTAENOIC ACID Icosapent cis-5,8,11,14,17-eicosapentaenoic acid omega-3-Eicosapentaenoic Acid BDBM50242349 Timnodonic acid vascepa cis-Delta(5,8,11,14,17)-eicosapentaenoic acid 5Z,8Z,11Z,14Z,17Z-eicosapentaenoic acid EPA all-cis-icosa-5,8,11,14,17-pentaenoic acid CHEMBL460026 (all-Z)-5,8,11,14,17-eicosapentaenoic acid ICOSAPENT ETHYL
Ac-His-Trp-Ala-Val-Gly-His-Leu-Met-NH2 CHEMBL274874 BDBM50012306
Ala-Phe-Trp-Ser-Tyr-Arg-Leu-Arg-Asp-Gly CHEMBL265381 BDBM50022915
BDBM142088 US8933056, Ala-boroPro Thioxamide US11559537, Compound 2243 US11096924, DASH-inhibitors 2243
BDBM50022513 CHEMBL3349389 H2N-Phe-Gly-His-(S,S)-Sta-Ala-Phe-OMe
BDBM50042759 H-Tyr-D-Ala-His-Asp-Val-Val-Gly-NH2 CHEMBL125289
BDBM50042766 CHEMBL125872 H-Tyr-D-Ala-Trp-Asp-Val-Val-Gly-NH2
BDBM50089095 Met-Phe-Leu-Glu-Ala-Ile-Pro-Met-Ser-Ile CHEMBL216418
BDBM50117488 CHEMBL217362 H-His-Ala-Lys-Arg-Arg-Leu-Ile-Phe-NH2
BDBM50202349 CHEMBL218771 cyclo(-D-Tyr-L-Arg-L-Ala-L-Nal-Gly-)
BDBM50202357 cyclo(-D-Ala-D-Arg-L-Arg-L-Nal-Gly-) CHEMBL373440
BDBM50202367 cyclo(-D-Tyr-L-Ala-L-Arg-L-Nal-Gly-) CHEMBL374108
BDBM50202369 cyclo(-D-Tyr-L-Arg-L-Arg-L-Ala-Gly-) CHEMBL376513
BDBM50222726 CHEMBL393260 cyclo(-L-Am7(S2Py)-L-A1in-L-Ala-D-Pro-)
BDBM609780 US11707539, Compound 6489Gd BDBM609726 DOTA[Gd]- GABA-HyBz-D- Ala-boroPro
CHEMBL122159 BDBM50042765 H-Tyr-D-Ala-NalphaMePhe-Asp-Val-Val-Gly-NH2
CHEMBL218862 BDBM50202364 cyclo(-D-Tyr-D-Arg-L-Arg-L-Ala-Gly-)
CHEMBL219075 cyclo(-D-Tyr-L-Arg-L-Arg-L-Ala-Sar-) BDBM50202373
CHEMBL263698 BDBM50042763 H-Tyr-D-Ala-deltaPhe-Asp-Val-Val-Gly-NH2
CHEMBL373420 BDBM50202341 cyclo(-D-Ala-L-Arg-L-Arg-L-Nal-Gly-)
CHEMBL386427 BDBM50033568 Tyr-Ser-Phe-Lys-Asp-Met-Gln-Leu-Ala-Arg
CHEMBL390991 cyclo(-L-Am7(S2Py)-D-A1in-L-Ala-D-Pro-) BDBM50222735
CHEMBL393464 BDBM50222730 cyclo(-L-Am7(S2Py)-L-2MePhe-L-Ala-D-Pro-)
CHEMBL444094 BDBM50202352 cyclo(-D-Tyr-D-Arg-L-Ala-L-Nal-Gly-)
CHEMBL492713 N-Ac-D-Ala-Arg{N-omega-(N-methylcarbanoyl)}-OH BDBM50257292
DOTA-PABA-D- Ala-boroPro BDBM609535 US20240207292, Compound 6572 US11707539, Compound 6572
H-Tyr-D-Ala-Hfe-Asp-Val-Val-Gly-NH2 BDBM50042769 CHEMBL332416
H-Tyr-D-Ala-Phg-Asp-Val-Val-Gly-NH2 CHEMBL340909 BDBM50042761
H-Tyr-D-Ala-Tyr-Asp-Val-Val-Gly-NH2 CHEMBL334299 BDBM50042767
Tyr-Ser-Phe-Lys-Asp-Ala-Pro-Leu-Gly-Arg BDBM50033566 CHEMBL427936
Tyr-Ser-Phe-Lys-Asp-Met-Pro-Ala-Gly-Arg CHEMBL413642 BDBM50033571
US11707539, Compound 4536B US20240207292, Compound 4536B DOTA-HyBz-D- Ala-boroPro BDBM609379
US11707539, Compound 6509 DOTA-Ser-D- Ala-boroPro US20240207292, Compound 6509 BDBM609575
US20240207292, Compound 6512 BDBM609725 US11707539, Compound 6512 DOTA-Gly-D- Ala-boroPro
Z-Pro-Phe-His-LeuP(CH2)Val-Ala-Sta-OMe BDBM50017799 CHEMBL427576
cyclo(-D-Tyr-D-Ala-L-Arg-L-Nal-Gly-) BDBM50202343 CHEMBL384429
cyclo(-L-Am7(S2Py)-D-2MePhe-L-Ala-D-Pro-) CHEMBL393261 BDBM50222731
somatostatin-28 L-Ser-L-Ala-L-Asn-L-Ser-L-Asn-L-Pro-L-Ala-L-Met-L-Ala-L-Pro-L-Arg-L-Glu-L-Arg-L-Lys-L-Ala-Gly-L-Cys(1)-L-Lys-L-Asn-L-Phe-L-Phe-L-Trp-L-Lys-L-Thr-L-Phe-L-Thr-L-Ser-L-Cys(1)-OH BDBM82460
BDBM50291976 6-Amino-2-(2-{2-[2-[2-(2-amino-propionylamino)-4-methyl-pentanoylamino]-3-(4-hydroxy-phenyl)-propionylamino]-propionylamino}-3-hydroxy-propionylamino)-hexanoic acid [1-(1-carbamoyl-2-hydroxy-ethylcarbamoyl)-3-methyl-butyl]-amide Ala-Leu-Tyr-Ala-Ser-Lys-Leu-Ser-NH2 CHEMBL448105
CHEMBL2370117 4-{2-[2-(4-{2-[2-(2-Amino-4-carboxy-butyrylamino)-propionylamino]-3-carbamoyl-propionylamino}-3-hydroxy-6-methyl-heptanoylamino)-3-methyl-butyrylamino]-propionylamino}-4-(1-carboxy-2-phenyl-ethylcarbamoyl)-butyric acid(NH2-Glu-Ala-Asn-Sta-Val-Ala-Glu-Phe-COOH) BDBM50108526
BDBM50012314 (CH3)CCO-His-Trp-Ala-Val-Gly-His-Leu-Met-NH2 CHEMBL440986
BDBM50117496 H-His-Ala-Lys-Arg-Arg-Leu-Ile-(L)-Pse-OH CHEMBL429171
BDBM50202345 cyclo(-D-Tyr-D-Arg-L-Arg-L-Nal-D-Ala-) CHEMBL373636
BDBM50202359 cyclo(-D-Tyr-L-Arg-L-Arg-L-Nal-D-Ala-) CHEMBL375990
BDBM50202361 CHEMBL387120 cyclo(-D-Tyr-L-Arg-L-Arg-L-Nal-L-Ala-)
CHEMBL267119 H-His-Ala-Lys-Arg-Arg-Leu-Ile-(L)-Phe omegaCH2OH BDBM50117492
H-His-Ala-Lys-Arg-Arg-Leu-Ile-(D)-Pse-OH BDBM50117499 CHEMBL412632
H-His-Ala-Lys-Arg-Arg-Leu-Ile-(Z)-Dhp-OH CHEMBL384574 BDBM50117490
cyclo(-D-Tyr-D-Arg-L-Arg-L-Nal-L-Ala-) BDBM50202360 CHEMBL376811
cyclo(-D-Tyr-D-Arg-L-Arg-L-Nal-beta-Ala-) CHEMBL219135 BDBM50202355
cyclo(-D-Tyr-L-Arg-L-Arg-L-Nal-beta-Ala-) CHEMBL375991 BDBM50202344